New! Proximity Protected Location Map (From data.ny.gov)
Introducing the Legal Online Cannabis Activities Locator (LOCAL) Map!
September 29, 2024 – OCM has introduced a new mapping tool for searching out Adult-Use, MicroBusiness, Medical Dispensaries, and Coming Soon (in the same categories). The map is easy to use, and has a wealth of information. You can access information about open and soon-to-be-open facilities, including license number, address, license type, and website.
Where Does Donald Trump Stand On Cannabis Reform?
November 10, 2024 – Kamala Harris made her views clear on cannabis reform. She supported re-scheduling and possibly legalization at the federal level, and was prepared to offer a raft of incentives to support social equity programs.
Donald Trump may be a bit harder to read, but at least at the state level, taking him at his word, he supported (even endorsed) the failed effort in Florida to legalize adult use cannabis.
He supported changes to the banking laws sought by cannabis industry players. He also supported the cannabis rescheduling process initiated by the Biden administration, with hearings scheduled for the first weeks of his new term.
Of course, voicing support is very different than taking the steps necessary to implement actual reforms.
Republicans generally oppose marijuana reform. Changes to the banking laws (in whatever shape they take) have to be initiated and pass the new Republican Senate majority.
Also, Trump can’t act alone. Whomever he chooses to serve as Attorney General will put his or her own imprint on how the federal government interacts with those states that have passed adult use cannabis laws. In Trump’s last go-round, Attorney General Jeff Sessions walked back Obama’s hands-off approach to federal involvement in state cannabis industries. We don’t know yet who Trump will choose as Attorney General, but prosecutorial discretion lies largely (but not exclusively) with the AG’s office.
Regarding the Florida legalization effort, Trump said, “someone should not be a criminal in Florida, when this is legal in so many other States. We do not need to ruin lives and waste taxpayer dollars arresting adults with personal amounts of it on them, and no one should grieve a loved one because they died from fentanyl laced marijuana.”
From his statement, one can glean that he is at least aware of the rigorous testing and stringent licensing laws that enable safe, clean, untainted product produced by licensed cultivators and processors and the sold through regulated retailers. We can assume he knows the risks of selling untested cannabis from unlicensed sellers.
Trump did express some concerns about the Florida initiative, and said, “We need the State Legislature to responsibly create laws that prohibit the use of it in public spaces, so we do not smell marijuana everywhere we go.”
“In Florida, like so many other States that have already given their approval, personal amounts of marijuana will be legalized for adults with Amendment 3,” Trump said. “Whether people like it or not, this will happen through the approval of the Voters, so it should be done correctly.”
Despite Trump support for both medical marijuana as being “absolutely amazing” for patients, and adult use marijuana in Florida, the initiative did not garner the 60% of the vote necessary for passage.
Remember that during Trump’s first term, he signed a sweeping agriculture bill that legalized the production of hemp after decades of prohibition. And, during his first term, he supported a bill that allowed states to set their own cannabis policies, outside of federal law.
His clearest declaration of support came during the campaign when he said his administration would “continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws, including safe banking for state authorized companies, and supporting states’ rights to pass marijuana laws, like in Florida, that work so well for their citizens.”
So, whichever way the election went, the two candidates shared a basic approach to cannabis – letting the states continue to decide, supporting banking reform efforts, and rescheduling. Legalization at the federal level may have stood more of a chance under a Harris administration.
The major uncertainties now are Trump’s choice for Attorney Geneal and how independent that person is in his or her thinking, and how conservative the new Republican majority in the Senate will be on the issue.
The other issue, less spoken about, is the influence of Christian Nationalism on marijuana policy – with some saying cannabis is God’s perfect medicine, and other saying cannabis use is a sin. Given the influence Christian Nationalists have on the Republican Party, their views can neither be discounted nor ignored.
For these issues and how they play out, we’ll have to wait and see.
Cannabis Rescheduling Pushed Back To 2025; More Questions Than Answers
November 10, 2024 – Hopes for rescheduling of cannabis before year-end were dashed when Chief Administrative Law Judge (ALJ) John Mulrooney found fault with the DEA’s list of witnesses.
Mulrooney said the list was inadequate for purposes of the hearing. It was sent without addresses or phone numbers and failed to state whether the interested party would be adversely affected or aggrieved by the proposed regulation change.
The hearing, scheduled to start on December 2nd won’t include witness testimony or documentary evidence until at least early January or February of 2025.
The order included a letter from the DEA’s Anne Milgram listing her approved list of witnesses:
- Village Farms International (VFF), Shane Pennington of Porter Wright
- National Cannabis Association (NCIA) Aaron Smith and Michelle Rutter Friberg
- American Academy of Hospice and Palliative Care, Dr. Chad Kollas MD
- Cannabis Bioscience International Holdings, John Jones
- Hemp for Victory
- State of Connecticut Cannabis Ombudsman Erin Kirk
- Massachusetts Cannabis Advisory Board, Ellen Brown
- Veterans Initiative 22, Shanetha Garulay
- The Doc App, dba My Florida Green, Nicholas Garulay, Jason Castro
- The Commonwealth Project, Katy Green
- Saint Michael’s College, Ari Kirshenbaum PhD
- National Drug and Alcohol Screening Association, Jo McGuire
- Smart Approaches to Marijuana, Patrick Philbin
- International Academy on the Science and Impact of Cannabis, Roneet Lev
- Cannabis Industry Victims Educating Litigators, David Evans Sr.
- Kenneth Finn MD
- National Transportation Safety Board, Jennifer Homendy
- Phillip Drum, Pharm D
- State of Nebraska, Attorney General Mike Hilgers
- International Association of Chiefs of Police
- Drug Enforcement Association of Federal Narcotics Agents
- American College of Occupational and Environmental Medicine, Natalie Hartenbaum
- Community Anti-Drug Coalitions of America, Sue Thau
- Tennessee Bureau of Investigations
- National Sheriff’s Association
The participants were told that they needed to provide additional information by Nov. 12 including their names, addresses, phone numbers and the general mission of their practice or business. The list did include email addresses for each proposed witness.
The hearings will be livestreamed with media access granted to a limited number of credentialed media.
Questions legal and financial experts are studying include how rescheduling affects banking and other laws. As reported in Forbes: The American Institute of Certified Public Accountants sent a letter to the Internal Revenue Service and the Department of the Treasury on Monday, urging them to update their guidance for cannabis businesses.
This request comes as cannabis may soon be rescheduled to Schedule III of the Controlled Substances Act, which would allow these businesses to operate without the restrictions imposed by section 280E.
Recommendations included retroactive treatment for expenses previously subject to section 280E, clarification of issues stemming from prior section 280E disallowance, uniform tax treatment among cannabis businesses, and a volunteer disclosure program that would allow business previously subject to 280E’s restrictions to understand the new landscape without fear of repurcussion.
New York State Senator Bill Weber to Introduce Legislation Reining in Office of Cannabis Management Amid Social Equity Fund Mismanagement
October 27, 2024 – State Senator Bill Weber announced today he will introduce legislation in the upcoming legislative session to impose strict safeguards on the Office of Cannabis Management (OCM). The Senator says the law is in “response to the alarming revelations of mismanagement and excessive compensation within the New York Cannabis Social Equity Investment Fund.”
The proposal comes in the wake of news that managers of the public-private Social Equity Fund, established to implement the primary mission of New York’s cannabis laws have made millions managing the fund with few successes to show for their efforts According to a report originating with “The City” magazine, managers earned about $1.7 million in the past year while the Fund has faced charges of predatory lending, secrecy and mission failure.
According to Weber, the decision follows a report detailing how the fund, meant to help those harmed by New York’s outdated drug laws, has only opened 21 dispensaries out of the 150 initially promised. The legislation aims to address the lack of accountability and transparency that has plagued the fund and the state’s cannabis regulation efforts.
“This is not how New York State should be handling its cannabis legalization process,” said Senator Weber. “The very individuals we set out to help are being left behind, while fund managers profit off the backs of New York taxpayers. The time for change is now.”
The proposed legislation will:
- Mandate greater transparency from the Office of Cannabis Management, including detailed public reporting on fund disbursements, management fees, and the progress of social equity licensees.
- Implement strict caps on management fees to ensure more resources are directed toward helping social equity applicants, not enriching fund managers.
- Establish clear benchmarks for the opening of social equity dispensaries, with penalties for failing to meet those goals.
- Require legislative oversight for all future contracts involving state cannabis funds to prevent further instances of excessive compensation and written quarterly reports to the oversight committees.
“Governor Hochul’s administration must be held accountable for allowing this mismanagement to continue,” Weber added. “This legislation will ensure that the Office of Cannabis Management is reined in and that the fund’s true mission—to promote social equity—is finally prioritized.”
According to Weber, the bill is expected to garner bipartisan support, as both Democratic and Republican lawmakers have raised concerns about the inefficacy of the current system.
Attorney General James Secures $9.5 Million Judgment Against Unlicensed Cannabis Store Owner in Ontario County
October 27, 2024 – Canandaigua Dispensary Owner Fined $9.5 Million for Selling Cannabis Without a License and Ignoring Notice to Stop OperatingNew York Attorney General Letitia James secured a $9.5 million judgment against the owner of an unlicensed cannabis dispensary in Ontario County. George West, the owner of the unlicensed dispensary Jaydega 7.0, ignored a June 2023 notice and order from the Office of Cannabis Management (OCM) to stop operating without a license. The Office of the Attorney General (OAG) and OCM obtained a judicial closing order that shut down Jaydega 7.0 in November 2023. The money judgment requires West to disgorge more than $1 million of illegal profits he got from selling cannabis without a license and pay $8.4 million in penalties for continuing to sell cannabis after being ordered by OCM to stop.
New York’s Cannabis Law requires any person who cultivates, processes, or sells any cannabis product to be registered and licensed by the New York State Cannabis Control Board. The law imposes a $10,000 penalty for each day an individual sells cannabis without a license, and a $20,000 penalty for each day an individual continues to sell cannabis after receiving an order to cease operating from OCM. Additional revenue-based civil penalties may also be imposed based on the amount of the unlicensed sales. The $9.5 million judgment against West resulted from a combination of disgorgement, administrative fines, daily penalties, and revenue-based penalties for West’s unlicensed activities.
George West operated his cannabis store on Main Street in Canandaigua and was selling cannabis without a license since at least September 2022. On June 28, 2023, OCM conducted an administrative inspection of Jaydega 7.0, confirmed West was selling cannabis without a license, and seized more than 200 pounds of cannabis and cannabis products. Following the inspection, OCM sent West a notice and order to stop operating and requested West provide an accounting and full financial disclosure of his operations at Jaydega 7.0. Although West refused to provide this information, OCM obtained financial records showing that West recorded nearly $2.4 million in sales revenue from June 2022 through October 2023. West continued to sell cannabis without a license until OCM and OAG obtained a court order mandating the closure of the Jaydega 7.0 store in November 2023.
Cannabis products sold by unlicensed businesses are not lab tested by OCM facilities, can be unsafe, and are not taxed. The OAG is authorized upon request by OCM to bring a proceeding against any person who violates the Cannabis Law.
The Community Reinvestment Program Grant Application Is Now Open!
October 27, 2024 – If you’ve been wondering when and where taxes collected from cannabis sales were going going to find their way back into your community, the wait may be over.
New York’s Office of Cannabis Management is accepting grant proposals for a $5 million community reinvestment program funded by cannabis sales. The grants are for nonprofits serving people 24 years and under that target mental health, workforce development, or housing needs.
The state says the goal is to distribute the funds to “areas of the state that have been historically under-resourced, underserved, and over-policed” and disproportionally affected by harsh drug policies of the past. The total available funding for this grant opportunity is $5,000,000. Grants will be for $100,000.
“If anyone needs another reason why buying cannabis from licensed dispensaries is the best option, here you go,” Tabatha Robison, OCM’s director of economic development, said in a statement about the program. “Every dollar spent in a legal shop contributes to the important work of reinvesting in communities harmed by prohibition.”
Taxes from legal adult-use cannabis sales in New York State go into the Cannabis Revenue Fund. Per the Cannabis Law, 40% of Cannabis Tax Revenue goes back to the communities most disproportionately affected by prior drug policies in the form of grants overseen by the Cannabis Advisory Board (CAB) via the Community Grants Reinvestment Fund. Through these grants, it is the goal of OCM and the CAB to distribute impactful funding to areas of the state that have been historically under-resourced, underserved, and over-policed.
By law, the Community Reinvestment Program may be designed to fund such initiatives as job placement, job skills services, adult education, mental health treatment, substance use disorder treatment, housing, financial literacy, community banking, nutrition services, services to address adverse childhood experiences, afterschool and child care services, system navigation services, legal services to address barriers to reentry, including, but not limited to, providing representation and related assistance with expungement, vacatur, substitution and resentencing of marihuana-related convictions, and linkages to medical care, women’s health services and other community-based supportive services.
According to the guidance of the Cannabis Advisory Board, the program may choose to focus on different areas in the future. The grants from this program may also be used to further support the social and economic equity program created by the cannabis law and as established by the Cannabis Control Board.
Illegal Dispensaries Hurt Suburban & Rural Operators, Municipalities
September 29, 2024 – The problem of illegal, unlicensed dispensaries is not just an urban one, though most of the attention seems to be focused on New York City and other urban environs. Just north of NYC, in Rockland County, four of the five towns opted-out of cannabis retailing, and just a handful of villages opted in. In Rockland, a county of over 330,000 people, there is one licensed, operating dispensary.
That said, it is possible to buy cannabis just about everywhere around the county. Put yourself in the shoes of the legal operator who spent a large fortune securing its license, its storefront, its inspected inventory. How is that dispensary supposed to compete with the illegal operator? What about the municipal government that opted in to receive a share of sales tax revenue? And, what’s to do about the wholesalers and distributors in New York (and elsewhere) who supply the illegal operator with product?
In a small victory for both the sole licensed operator and the Village of Piermont, Village officials (with the help of New York State) closed down the Hazy Joint, operating openly and illegally on Route 9W in Piermont. The Hazy Joint operated for months just steps from a licensed dispensary that had yet to open its doors, not knowing if it ever could, or how it would, compete with an illegal seller less than 500 feet away.
Well, that operation is padlocked, its merchandise seized. What happens next is up in the air, but it would seem that the best course is to come down on the landlord (who should have a duty to know who it is renting to), and more importantly, the suppliers (wherever they are). The Hazy Joint is just one of too-many-to-count illegal operators in Rockland County. It is likely the same elsewhere, everywhere.
Federal Advisory Panel Calls For Larger Government Role In Cannabis As Flower Potency Increases
September 29, 2024 – Marijuana is more potent and contains more THC than in years past.
Earlier this week, the Centers For Disease Control & Prevention reported the need for the federal agency to take a deeper dive into cannabis policy and health.
About 18 million Americans acknowledge daily, or near-daily, cannabis use. That number exceeds the number drink alcohol.
“We’d like the federal government to step up to provide some leadership in this area,” said Dr. Steven Teutsch of the University of Southern California, Chair of the Committee behind the National Academies of Sciences, Engineering and Medicine report. The CDC and the National Institutes of Health sponsored the report. A CDC spokesperson said Thursday that the agency would study the recommendations and that more money would be needed to implement them.
Thirty-eight states and the District of Columbia allow the medical use of marijuana, with many of them also accommodating legal adult recreational use. Come this November, Florida will likely join the ranks on recreational adult use.
And, while local and state governments benefit from sales taxes on cannabis, marijuana remains illegal under federal law.
Twenty-five years ago, cannabis flower contained about 5% THC.
“Now you go into the stores, it’s hard to find products that are less than 20% THC,” said Beau Kilmer, co-director of the RAND Drug Policy Research Center and a report committee member.
As reported on pbs.org, among the report’s recommendations for the CDC:
- Develop and evaluate health campaigns about cannabis, specifically for parents, young people, pregnant women and people 65 and older.
- Monitor cannabis cultivation, sales, use and health impacts.
- Create best practices for state regulation, including ways to limit youth access.
For Congress:
- Close a loophole that allows intoxicating products derived from hemp to be widely sold, even in states where other cannabis products are illegal.
- Remove restrictions on the Office of National Drug Control Policy that prevent it from studying the effects of cannabis legalization.
For states:
- Require training and certification for cannabis retail staff.
- Automatically expunge or seal records for low-level cannabis-related offenses in states that have decriminalized cannabis.
- Adopt and enforce quality standards set by the U.S. Pharmacopeia, an independent group that sets standards in medicines and dietary supplements.
New Jersey Update (From Upcoming Marijuana Monday – New Jersey Edition
|
There are currently 41 cannabis cultivators operational which means the market now has a wider variety of products.
Hemp Sellers Fight Back
September 2, 2024 – Licensed sellers of hemp have been treated arbitrarily, illegally, and according to a lawsuit filed by a group of hemp sellers from New York City to Saratoga Springs, with Gestapo-type tactics, including raids by heavily armed SWAT teams.
The suit, filed last week in Albany County Supreme Court against the Cannabis Control Board, the Office of Cannabis Management, and the New York City Sheriff’s Office seeks a temporary restraining order and a preliminary injunction stopping New York State officials from engaging in warrantless military style raids against lawful licensed hemp retailers selling legal hemp products.
Plaintiffs also ask the court to rein in defendants and require them to cease applying MRTA regulations applicable to marijuana retailers during inspections of lawful licensed hemp retailers selling legal hemp products.
They complain that OCM and inspectors are adjudicating the legality of hemp products based on packaging rather than testing the actual product. They challenge the seizure and retention of hemp products without meaningful hearings. And, they challenge the legality of the state’s Revised Hemp Regulations because they are pre-empted by Federal Law. Plaintiffs say that federal law defines hemp, and that the state cannot impose additional or more stringent definitions than the federal rules allow.
The complaint details the raids, arrests, seizures, and padlocking of licensed hemp sellers by overzealous state and municipal officials, including the closure of stores and signage effectively labeling the store as having sold illicit cannabis though the owners say they were selling legal hemp products, and the harm that the signage has done to their ongoing businesses.
The complaint details the farcical nature of the hearings, the lack of review of product certifications, the refusal to test seized products, and the refusal to return seized products. Plaintiffs tell of officials efforts to frustrate the store owner’s relationship with their landlords and efforts to seize of the retailer’s financial accounts by labeling the lawful retailer a “criminal.”
Plaintiff’s charge: “Respondents’ Gestapo-like conduct cannot continue unabated. Respondents must not be permitted to violate the constitutional rights of small business owners who invested time and money to obtain a license at great expense to sell a legal, licensed product. Without swift action by this Court, Respondents’ unconstitutional actions will continue in violation of fundamental constitutional rights, and Petitioners and many other licensed hemp retailers will suffer irreparable harm. Judicial action is necessary to put an end to Respondents’ unconstitutional enforcement scheme.”
On Friday, the Court ordered the OCM and other defendants/respondents to appear in Court on September 13th and defend their tactics, effectively requiring the state to “show cause” why the hemp sellers should not get the relief they seek.
These sort of heavy-handed tactics are not used against sellers of alcohol or tobacco who run afoul of the law. Everyone agrees that the closure of unlicensed cannabis sellers is a legitimate (and necessary) goal of the state, but the tactics employed seem to outweigh the necessity of the actions taken. Where constitutional rights are trampled to achieve an economic goal, court intervention is necessary.
Sales Tax Revenue Starts To Flow Back To Local Municipalities Where Cannabis Is Sold
August 24, 2024 – For all of the excitement over gross revenue, the flow of tax dollars to municipalities has been – well – slow.
The total amount distributed to counties and to New York City through July 31, 2024 is $13.7 million. Counties are required to share the bulk of the sales tax revenue with local towns and villages where the revenue is actually generated
Of that $13.7 million paid to date, $4.5 million went to New York City (where 68 dispensaries operate legally); $5.9 million went to Upstate communities; and $3.2 million went to downstate communities, excluding New York City.
Downstate includes Dutchess, Nassau, Orange, Putnam, Rockland, Suffolk, Sullivan, Ulster and Westchester. None of the towns/villages in Nassau County opted in, so no tax revenue flows there. Putnam has no operating dispensaries.
Upstate includes every other county north of the Downstate counties. New York City includes its five boroughs.
The map below shows tax distribution and the number of operational dispensaries in each county.
So, where is the money?
In the first quarter of 2024, about $100 million worth of cannabis was sold. In the second quarter of 2024, over $160 million worth of cannabis was sold, and according to OCM, the third quarter should surpass the second quarter.
OCM said for the second quarter of 2024, that’s about $23 million in cannabis taxes.
New York imposes a 13% sales tax to all cannabis products that are sold retail. 9% stays with the state. 4% goes to the municipalities where these transactions were done with the bulk of that money going to the town or village where the dispensaries are located.
AUC retailers must file tax returns and remit payment of taxes due on a quarterly basis with the New York State Department of Taxation and Finance. The revenue associated with these payments will be distributed to local governments in January, April, July and October.
So, again, where’s the money?
(Map: Office of State Comptroller)
Anti-Cannabis Group Files Another Lawsuit Seeking To Undermine Cannabis Industry
August 6, 2024 – The Cannabis Impact Prevention Coalition and the Cannabis Industry Victims Seeking Justice and filed suit in State Supreme Court in Albany County claiming that CCB, OCM, the Dormitory Authority, the Department of Taxation and Finance and others are using state money illegally in support of MRTA and MRTA’s various programs supporting cannabis cultivation, distribution, distribution and other endeavors related to cannabis.
Plaintiffs claim to represent the victims of cannabis as well as taxpaying citizens of the state who argue that using state funds in support of the cannabis industry is contrary to both state and federal law.
The arguments raised focus around the state’s NYS Cannabis Revenue Fund, a vehicle for collection and disbursement of taxes and fees raised from the cannabis industry. In a nutshell, plaintiffs argue that New York State and all of the entities established by it that are involved in cannabis are violating the Controlled Substances Act in numerous ways.
Derivatively, they also argue that those same expenditures violate New York State law. Plaintiffs as citizen-taxpayers charge that can maintain an action for declaratory relief against state authorities who have “caused, is now causing, or is about to cause a wrongful expenditure, misappropriation, misapplication, or any other illegal or unconstitutional disbursement of state funds.”
For relief, they seek a temporary and permanent injunction against state authorities prohibiting them from using state funds in furtherance of cannabis, as well as declaratory relief that MRTA violates both state and federal law.
This is not the first attempt by these plaintiffs to derail New York’s cannabis industry. Last year, the group filed a federal lawsuit against New York and the state Office of Cannabis Management, alleging that the State’s Social Equity Fund was illegal.
Before that, the coalition filed suit to overturn MRTA alleging that the underlying claims supporting passage of MRTA and about cannabis were fraudulent.
According to its website, the Cannabis Impact Prevention Coalition is a grassroots coalition made up of concerned citizens, parents, healthcare professionals, educators, treatment providers, law enforcement, and other professionals whose mission is to prevent the social, health, public safety and environmental impacts of marijuana/cannabis.
Proximity Protection Upheld By Albany County Supreme Court
August 4, 2024 – Update on the proximity protection litigation pending in the Supreme Court, Albany County. Readers will recall that Gracious Greens, LLC (GG) filed suit challenging the cannabis regulations both on their face and as applied in denying GG its preferred locations in New Paltz and Peekskill, where Valley Greens and Big Gas Dispensary already enjoyed proximity protection for their nearby locations.
To undermine that protection, GG argued: (1) that municipalities should decide cannabis dispensary locations, not OCM; (2) that taking away municipal discretion violated New York’s Home Rule law, which generally allows local governments to make decisions affecting their zoning and related land-use issues; and (3) that the proximity protection regulations were too vague to pass constitutional muster, both as written and as applied.
In a well-reasoned opinion, the Court rejected those claims and denied GG the temporary relief it sought.
The Court addressed the merits of GG’s claims and rejected its interpretation that the final say-so of location approval rests with the municipal government, as the legal framework clearly gives the CCB the last word on licensing a dispensary at a particular location.
On the Home Rule argument, the Court found the rules promulgated by CCB were applicable statewide and did not infringe on a local jurisdiction’s home rule. It found the statutory scheme to be of general application, effectively trumping (so to speak) any effort by a municipality to make a decision inconsistent with the statewide law.
And, of the vagueness claims (constitutional due process claims) the Court effectively found the law passed constitutional muster. It found the laws neither vague nor applied arbitrarily or in a discriminatory manner. The Court found the proximity protection provision clear on its face. The Court considered plaintiff’s argument that not knowing what areas were protected at the time it applied to secure their preferred locations, it could not know that its chosen locations were ineligible for licensure, and kind of skirted the argument, saying that nothing in the regulations prevented GG from applying for a license at a location that was already protected.
In a lengthy discussion, the Court also rejected the possibility that GG would succeed on the merits of its claims and denied it the injunctive relief it was seeking. What comes next is a bit unclear. The case proceeds for now – but the judge has made his views on the merits pretty clear.
Governor Hochul Has Bills Sitting On Her Desk That Could Help Stabilize New York’s Cannabis Industry
August 4, 2024 – Bills sitting on Governor Kathy Hochul’s desk could improve the economic prospects of participants in New York’s cannabis industry.
Several bills made it past both the Assembly and Senate and await signature, veto or lapse at year-end.
While cannabis suppliers won a victory when the State replaced the potency tax with a flat tax, and the change from quarterly to annual tax payments helped, there are other measures that growers and processors say are important and necessary.
The Cannabis Association of New York released data last week detailing its concerns over possible supply shortages, particularly as new dispensaries open their doors. The issue is: can supply keep up?
78% of dispensary owners and 66% of processors say cultivators and suppliers plan to ship less cannabis product. 53% of cultivators say they cannot meet order requests. And, about 27% of that group claims they often fail to fill orders.
In contrast dispensary sales are on the rise, with an average 17% month-over-month growth rate, according to the Office of Cannabis Management.
So, what are stakeholders looking for?
One, they want Hochul to sign a measure into law that would define cannabis as an agricultural crop under state law, removing the stigma of growing cannabis and opening new options for growers with municipalities and AgMarkets.
Long on the table is another bill that would make Cannabis Grower Showcases (CGS) permanent. Legislation would allow farmers to partner with dispensary owners, as they did in the past, to sell their products at approved events like markets, festivals and fairs, provided the municipality that the events were in had opted into cannabis retail sales. The pending bill would make the CGS program permanent and allow dispensary owner and growers to hold approved events for up to two weeks at a time.
The success of the CGS helped launch New York’s market, providing access to buyers when there were few dispensaries open for retail business. It also helped growers unload unsold product when the market could not yet absorb all of the grown cannabis.
Advertising Rules Relaxed For Retail Cannabis Shops
July 14, 2024 – New York’s restrictive rules governing advertising by licensed cannabis retailers have been relaxed by regulators who approved changes that will permit retailers to tout their locations on billboards and other external signage.
Proposed revisions also would also allow some marketing by company mascots, provided the dispensaries are not appealing to underage (under 21) customer. Also permitted will be a broader spectrum of colors on signage, and the introduction of promotional items such as sandwich boards, tee-shirts and handbills, within limits.
Retailers shared their disappointment that the rules prohibiting neon lighting, and the requirement that windows be tinted to prevent interior viewing from the outside, were not modified. Darkened windows leave dispensary staff vulnerable to robberies, and give the appearance that the legal sale of cannabis is still something to be hidden behind darkened windows. There are no similar rules for alcohol sales.
Retailers hoped that relaxing the rules would help level the playing field, not only with illegal sellers in New York, but against out-of-state sellers that advertise in New York.
The revisions still prevent images of cannabis, edibles and other products on billboard advertising. The changes, subject to a 45-day comment period, still restrict the content that can be shown. The new rules limit content to a retailer’s logo, name, and location address.
“New York’s packaging, labeling, and marketing regulations for cannabis are some of the most restrictive in the nation, making them incredibly challenging for brands, and we’re thankful the CCB acted (this week) to make at least some changes that will help brands in our state better compete,” said Mack Hueber, president of the Empire Cannabis Manufacturers Alliance, as reported in the Albany Times Union.
But he added that “far more work needs to be done to improve these regulations and boost our industry and, ultimately, the state should align its rules for marketing cannabis products with those that allow for creativity in the alcohol industry, while still protecting against advertising to youth.”
The rules, retailers hope, will soon mirror those for the sale of alcohol and tobacco, which allow generous advertising of their product in public view. Beer, wine, and liquor advertisements are viewable on network and cable television, without any restriction on age, and are prolific on sporting events which attract a diverse age audience.
The new regulations also allow retailers to offer loyalty rewards programs and discounted products.
These new regulations may level the playing field for licensed, tax-paying sellers who have to compete against illegal sellers that flout regulations, advertise widely, and sell to underage customers.
Board Approves 109 Adult-Use Licenses, Bringing Total Adult-Use Licenses to 730 Issued in 2024 Thus Far
July 14, 2024 – At its last meeting on July 10th, the CCB authorized the issuance of 109 adult-use cannabis licenses spanning the supply chain, encompassing microbusinesses, cultivators, processors, distributors, and retail dispensaries.
The breakdown of the 109 license types approved today includes:
- Adult-Use Cultivator License: 23
- Adult-Use Distributor License: 20
- Adult-Use Microbusiness License: 23
- Adult-Use Processor License: 22
- Adult-Use Retail Dispensary License: 21
58 out of the 109 are transitioning conditional cultivators or conditional processors.
For a complete list of the approved applications, click here.
IN BRIEF:
July 14, 2024 – A new analysis of violence between intimate partners concludes that legalizing marijuana for adult use “results in a substantial decrease in rates of intimate partner violence.”
The finding also indicate that recreational cannabis legalization “substantially impacts the relationship between heavy drinking” and intimate partner violence (IPV), possibly as the result of people substituting marijuana for alcohol.
Author Samantha Gene Baldwin, a Georgetown master of public policy student, wrote in the thesis that the findings are “surprising,” saying the links between recreational marijuana legalization (RML) and IPV “require careful consideration.”
Read the full story (Legalizing Marijuana Leads To ‘Substantial Decrease’ In Intimate Partner Violence, Study Shows) here:
Cannabis Control Board Approves 105 Adult-Use Licenses, Bringing Total Adult-Use Licenses to 654 Issued in 2024 Thus Far
June 14, 2024 – The New York State Cannabis Control Board (CCB) took substantial steps to advance the state’s cannabis regulatory framework during this month’s board meeting, addressing several key topics: license approvals, market updates, home grow regulations, and enforcement updates. The CCB authorized the issuance of 105 varied adult-use cannabis licenses spanning the supply chain, encompassing microbusinesses, cultivators, processors, distributors, and retail dispensaries. This move paves the way for entrepreneurs and businesses to enter the budding adult-use cannabis market, driving economic growth and fostering innovation.
“New York is building a robust and equitable legal market that is driving significant economic growth within our communities,” Governor Hochul said. “The issuance of 105 additional adult-use licenses is just the next step in developing the nation-leading industry New Yorkers expect and deserve.”
The breakdown of the 105 license types approved today includes:
- Adult-Use Cultivator License: 25
- Adult-Use Distributor License: 22
- Adult-Use Microbusiness License: 22
- Adult-Use Processor License: 19
- Adult-Use Retail Dispensary License: 17
- 45 out of the 105 are transitioning AUCC or AUCPs
The CCB also issued denials to 100 applications at the board meeting. These applications either did not meet the eligibility for licensure or had already been issued an adult-use cannabis license from another application.
The Office of Cannabis Management announced that in May alone, sales surged by $4.4 million, reaching a total of $46.2 million, and with the month ending with a new weekly sales record of $12.5 million.
Projections show that 2024 cannabis sales will exceed $200 million by early June, underscoring the sector’s rapid expansion and growing consumer capture.
Another Lawsuit Challenging Cannabis Board’s Social Equity Program
May 19, 2024 – Yet another lawsuit has been filed in State Supreme Court in Albany claims CCB acted arbitrarily, capriciously and illegally. The suit argues that the CAURD program is an “arbitrary and capricious” application of state law and that “and any and all licenses improperly granted pursuant to this program are invalid.”
The suit once again raises challenges to New York’s controversial Conditional Adult-Use Retail Dispensary (CAURD) program, which prioritized “justice-impacted” individuals who could demonstrate harm caused by the war on drugs.
In a lawsuit filed May 9 in state Supreme Court in Albany County against New York’s Cannabis Control Board and Office of Cannabis Management, four plaintiffs – Organic Blooms, Niagara Nugget, Blackmark and Windward Management – point out that CAURD applicants were able to file an initial request for a state license without securing real estate and alerting the local municipality.
The suit charges that those privileges were not extended to anyone who applied for a general license rather than a social equity permit during an October-December application window..
Plaintiffs filed their adult-use applications during the October-December application period and are still waiting to receive a decision from the state on their pending applications.
The lawsuit seeks declaratory relief and asks the court to invalidate the CAURD licenses issued to date, equating with the revocation of roughly 460 CAURD permits, including most of the 127 adult-use stores licensed to date.
Nearly all of the retail stores open in New York are CAURD licensees.
A copy of the lawsuit is available here.
Rescheduling Marijuana To Schedule III, What Does It Mean?
May 5, 2024 – According to the Associated Press, the Drug Enforcement Administration (DEA) has concurred with decisions made by the US Department of Health and Human Services (USHHS), advancing the move of marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Cannabis was first listed more than 50 years ago as a strictly prohibited drug, on par with heroin and LSD and defined as a substance with no known medical value and a significant abuse potential. Previous efforts to reschedule cannabis during the Obama administration were rejected.
USHHS determined that cannabis “has a currently accepted medical use in treatment in the United States” and has a “potential for abuse less than the drugs or other substances in Schedules I and II.”
The move to Schedule III will have a major impact on state-legal cannabis businesses, and not all of them good.
One positive business impact — marijuana firms can officially take federal tax deductions that they’ve been barred from under an Internal Revenue Service (IRS) code known as 280E.
One not so good. Marijuana would remain regulated by the DEA. That means, absent a legislative exemption, the roughly 15,000 cannabis dispensaries in the U.S. would have to register with the DEA like regular pharmacies and fulfill strict reporting requirements, something that they are loath to do and that the DEA is ill equipped to handle.
On the plus side, the proposed rescheduling would allow more research on cannabis. Research on cannabis as a Schedule I drugs extremely difficult and limited.
The move to Schedule I would not legalize marijuana at the federal level. Schedule III drugs are still controlled substances and subject to rules and regulations, and people who traffic in them without permission could still face federal criminal prosecution.
The rescheduling does not directly address another important issue to cannabis businesses – banking restrictions. There is legislation pending that would address banking as well as effort to de-schedule cannabis, which would remove it from the Controlled Substances Act.
“While this rescheduling announcement is a historic step forward, I remain strongly committed to continuing to work on legislation like the SAFER Banking Act as well as the Cannabis Administration and Opportunity Act, which federally de-schedules cannabis by removing it from the Controlled Substances Act,” Senate Majority Leader Sen. Chuck Schumer of New York said in a statement. “Congress must do everything we can to end the federal prohibition on cannabis and address longstanding harms caused by the War on Drugs.”
The next step in the rescheduling process is for the White House Office of Management and Budget (OMB), to review the rule. If approved, it would go to public comment before potentially being finalized.
New Litigation Filed Challenging License Issuance Under OCM’s Queue System
May 5, 2024 – A Hudson Valley applicant seeking a marijuana cultivation and processor license is suing regulators in the latest legal challenge to alleged “priority” status in the state.
Tree Hill Innovations, operated by its majority owner, Marguerite Mikol of Saugerties, filed a petition claiming certain applicants were given “extra priority” by submitting up to three applications in a lottery designed to vet requests, according to a story in the Albany Times Union.
The lawsuit against the state’s Cannabis Control Board and Office of Cannabis Management alleges regulators changed licensing application rules last year in an “arbitrary and capricious” manner without informing the public.
According to the suit, Mikol has invested more than $700,000 to establish operations, including the purchase of 67 acres in Ulster County.
“This is my livelihood that has been trampled and I would like to see correct policy implemented as it relates to the legislation and have my application reviewed under the current terms with approved time to correct or challenge any and all deficiencies,” Mikol wrote in court papers.
Mikol takes issue with allowing up to three duplicate applications to be submitted and says the change was made “without disclosing it to the public prior to the (second) application period … and suggests that it was established and implemented in an arbitrary and capricious manner.”
She also alleges that some applicants may have submitted more than three applications in the Office of Cannabis Management’s online queue to try and improve their chances of having one reviewed.
Mikol asks the Court to annul the queue system for license applications as arbitrary, capricious and without a rational basis in law. She says that they are outside the scope of OCM’s regulatory authority and in excess of its jurisdiction.
She also asks the Court to require transparency and reveal to the public the exact policies and procedures utilized in the creation and selections made from the queue. She asks for the existing queue to be vacated and for adherence to the law in any future queue system.
The Court has ordered OCM to “show cause” on June 7th in Albany why it should not grant the relief requested. The case has been assigned to Justice Justin Corcoran.
New York has been besieged by cannabis-related lawsuits regarding a variety of claims challenging: social equity licensing; residency requirements; a ban on third-party advertising for cannabis retailers; exclusion of multi-state operators; reverse discrimination of priorities and fees; and new rules governing hemp-derived cannabinoids.
Some of the litigation has stalled the rollout of the state’s cannabis program which Governor Kathy Hochul described as a “disaster.”
New York 2025 Budget Screws Growers, Replaces Potency Tax, Bolsters Local Law Enforcement, Eliminates State Share of Medical Excise Tax
April 21, 2024 – Maybe it’s just a disconnect. New York State Senator Jeremy Cooney is touting the accomplishments in the just-passed New York State Budget, what he calls Padlocks, Potency & Prescriptions, while ignoring the stab-in-the-back cultivators suffered when a proposed fund in the budget to help distressed cannabis farmers was removed from the state’s $237 billion spending plan during negotiations.
Cannabis farmers were expecting some relief in the budget. The proposed Senate version included provisions for cannabis farmers to access $60 million in loans, $40 million in grants, and $28 million in tax credits. Farmers would have accepted less and looked to the dairy bailouts from years past when the State recognized the importance of sustaining a failing agricultural market. They got nothing.
Cultivators are less than pleased. Joseph Calderone from the Cannabis Farmers Alliance said growers felt abandoned by the governor, that farmers are underwater and may be reconsidering planting this year, with some farmers looking to broker their licenses rather than lose more money.
Cannabis Farmers Alliance acting President Joseph Calderone said many cannabis farmers in the state are facing financial ruin. The CFA recently polled the state’s 289 licensed cannabis cultivators, and 97% of those who responded said they’re operating at a loss.
“The burden rate for our farmers is $300,000 a year,” Calderone said. “It’s really difficult to make business decisions.”
Meanwhile, there is some celebration with added enforcement at the local level, the replacement of the potency tax with a flat wholesale tax of 9%, and the elimination of the State’s share of the medical excise tax, keeping in place only the local tax share.
Municipalities will now be able to set their own local enforcement rules to padlock illicit shops and collect civil fines from the illegal businesses they shut down, creating some incentive for local governments to act.
The newest provision in the FY2025 budget addresses landlords. Landlords who turn a blind eye to the illegal activity and fail to bring forth eviction proceedings against tenants in violation of the cannabis law will be held to strict penalties including: a $50,000 fine for any landlord notified of the violation within New York City; or five times the rent from the time the landlord was notified of the violation outside of New York City.
The FY25 Budget also lowers the standard of proof required to evict a tenant in violation of cannabis law. Landlords will now only have to prove that a business is “customarily or habitually” engaged in selling cannabis without a license, rather than “solely or primarily” doing so.
The changes in the burden of proof are intended to eliminate a defense illegal sellers utilized to avoid closure and eviction – making it easier for landlords to remove unlicensed operators.
Court Tosses Regulations Banning Third-Party Platform Participation
April 7, 2024 – State Supreme Court Justice Kevin Bryant took no prisoners (pulled no punches) in his opinion last week on Leafly Holdings v. New York State OCM. In laymen’s terms, he basically said that OCM more or less “made up” regulations barring third party marketing firms from participating in New Yok’s legal cannabis market.
What third party marketers or platforms (TTPs) do is basically provide a sort of one-stop shop for cannabis information – who is selling legally, where they are located, what they are offering, what prices they are asking, how to order, etc. TTPs do not sell, fill orders, or deliver cannabis. They basically provide a marketing and educational vehicle for consumers. They create a check-and-balance on pricing by retailers by publishing competitive information, and allow retailers to market their products on the TTP’s database and mapping programs.
For reasons that were never articulated, or that were justified only after-the-fact, OCM’s regulations banned TTPs in New York. When regulations were first promulgated, Leafly, along with other TTPs, sought to participate in the drafting of the regulations, and for whatever reasons OCM had, it didn’t accept (probably didn’t even read) their input, or the input of similar entities. When the regulations were passed, Leafly had no option but to go to court this past September as it was effectively closed out of the nascent cannabis market in New York.
If claimed that the regulations were arbitrary, capricious, lacked a rational basis, were anti-competitive, violated the New York state constitution, and the US Constitution, largely because they sought to exclude TTPs based on the content of material that it sought to offer consumers. It said OCM wanted to competitive information away from consumers and keep consumers in the dark (and keep prices high) on product pricing from competing dispensaries.
OCM agreed in a temporary arrangement to allow Leafly to service New York while the litigation was pending, and then fought vociferously to have its regulations upheld and ultimately push Leafly out.
While the litigation was pending, Leafly, a publicly traded company, saw its stock price fall by one-half, presumably based on the possibility that it would be permanently barred from one of the potentially largest cannabis markets in the country.
Justice Bryant saw the regulations for what they were, and in a 13-page opinion struck the Third-Party Marketing Ban, the Pricing Ban, the Third-Party Order Ban, the Third-Party All License Listing Mandate, and the Third-Party Distributor Listing Mandate. He rejected the arguments made by OCM and detailed a complete lack of transparency, support, expertise, and process in the passage of the regulations.
He said that there was a “complete lack of justification for the action in the record” and that the “regulations constituted impermissible restrictions” on Leafly’s right to free speech and that they were also unconstitutionally vague.
Lawsuit Challenges Regulations On Proximity Protection
April 7, 2024 – Perhaps OCM needs to hire some additional lawyers.
Last week, a suit was filed in Albany Supreme Court against New York’s cannabis regulators that claims applicants were irreparably harmed because they had to secure retail locations outside of other retailers protected proximities without knowing where those protected areas were located.
The case filed by the law firm of Prince Lobel Tye for its client Gracious Greens, a service-disabled veteran and minority owned SEE candidate, says that its client secured municipal approvals for two locations in Peekskill and New Paltz only to discover that those locations already fell within proximity protection for other licensees.
An attorney from Prince Lobel told that New York Law Journal: “Finding an invisible competitor, not knowing where they are located, and being told, ‘Too bad, you should’ve known’ is incomprehensible.”
The complaint says the proximity regulation is void for vagueness, fails to provide a person with ordinary intelligence with a reasonable opportunity to know what is prohibited, and is written in a manner that encourages arbitrary or discriminatory enforcement.”
The action also takes issue with regulators usurping local municipal planning and zoning by reserving the final say on location with OCM.
As written, the regulations forbid dispensaries from locating within a 1,000 foot radius of another dispensary in municipalities with populations of 20,000 people or more, and a 2,000 foot radius where populations number less than 20,000 people.
The suit basically asks to do away with proximity protection in the earlier application window because applicants were told to secure locations without knowing if they would be acceptable to OCM’s grant of proximity protection to other retailers.
Last month, OCM put out an interactive map designating current and pending storefronts.
Cannabis Farmers Relief Fund Proposed For New York Budget
March 20, 2024 – If the New York State Senate has its way with this year’s budget, cannabis farmers can expect some relief. The proposed Senate budget include provisions for cannabis farmers to access $60 million in load, $40 million in grants, and $28 million in tax credits.
Last year, Governor Hochul vetoed legislation that would have allowed cannabis farmers and cultivators to offload tested, packaged, and sealed cannabis products and cannabis to a cannabis dispensing facilities licensed by a tribal nation for retail. The legislation would have created a new avenue for sales for cannabis farmers.
The Cannabis Farmers Relief Fund will require proof of financial hardship before licensed cultivators and processors could access benefits.
Potency Tax Repeal Considered
March 20, 2024 – The Senate budget proposal also repeals the potency tax and replaces it with a wholesale flat tax that would start at 5% come June 1, 2024, but comes with a catch. The flat tax would increase to 7% in 2028 and then up to 9% in 2031. Governor Hochel proposed a 9% flat tax. The Senate version gives a few years of relief before each boost in the tax.
Also considered is a repeal of the medical cannabis excise tax. New York State currently has one of the highest tax rates on medical cannabis in the nation. Bordering states, including Connecticut, Massachusetts, New Jersey, Rhode Island, and Vermont have no excise tax on medical cannabis products whatsoever.
COD List? What’s That About?
In New York State, licensed retailers who purchase cannabis products from licensed suppliers are required to pay in full for the purchase no later than 30 days from the date of delivery. Suppliers are required to report to the Office of Cannabis Management any retail licensee who, after 30 days from delivery date, still has an outstanding balance due for a credit purchase.
Suppliers are also required to send a “Notice of Default” and upload a copy to OCM when reporting delinquent payments. When payment is received in full from the retailer, suppliers must send a notice to OCM of receipt of payment to remove the retailer from the COD (Cash On Delivery) list.
The list is not public, and OCM does not act as a collection agency for past due receivables. OCM simply determines the validity of the report before placing a retailer on the COD list. Retailers remain on the list until past due invoices are cleared.
If a retailer appears on the list, no supplier can sell cannabis products to it on credit. Suppliers are required to check the COD list before extending credit. Licensed retailers can request information about the C.O.D. list by emailing CODReporting@ocm.ny.gov. The Office will provide the retailer with information specific to your business only. If on the C.O.D. list, OCM will provide the name of the supplier(s) who reported you as delinquent and how much they claim you owe them.
Powerhouse Pacific Legal Foundation Joins The Fray Challenging New York’s SEE Licensing Preferences
March 11, 2024 – January’s lawsuit by Jamesville, New York’s Valencia, AG LLC was largely minimized (and sometimes laughed at) by New York’s Cannabis Bar – the commentaries of experts who predict the outcomes of every lawsuit, even though most have been resolved by settlement and not litigation.
Valencia’s lawsuit, filed in the United States District Court for the Northern District of New York challenged the advantages given to women and minority applicants in retail licensing by the Office of Cannabis Management. According to the lawsuit, the plaintiff was owned by “males of light pigmentation who might best be described as Caucasian or white men.” Valencia filed an application with OCM on October 12, 2023 seeking a microbusiness cannabis license. Not falling into any of the categories for SEE status, Valencia was unable to request any sort of priority status in its application.
In OCM’s randomized hierarchy for reviewing applications, Valencia ranked 2,042 out of what was supposed to be 2,200 “operationally-ready” applicants and knew he had no chance of having his application reviewed or receiving a coveted license.
The complaint alleged that the preference or priority given to women and minorities, over white men, violates the Equal Protection Clause of the United States Constitution. Plaintiff also charges that the higher application fees paid by white men over women and minorities also violates the US Constitution.
For relief, Plaintiff asks for: (1) a preliminary and permanent injunction against the preferences given women and minorities; (2) a prohibition against OCM from processing any applications for cannabis licenses where those applications claim SEE status based on women or minority ownership; (3) the revocation and cancellation of licenses granted to SEE status licensees when based on women or minority ownership; (4) a refund of the higher application fees paid by applicants unable to claim SEE status based on women or minority ownership; and (5) a prohibition against the differing fee schedules based SEE status.
Valencia’s request for a temporary restraining order was denied when the District Court found that the plaintiff had not demonstrated that it would suffer irreparable harm waiting for a full hearing on a preliminary injunction. That ruling was sound.
With the hearing originally set for Thursday, March 14th, OCM filed its affirmations, hundreds of pages of exhibits and memoranda of law in opposition to the request for a temporary injunction. It referred to the harm to applicants, farmers, processors, the market in general, and how an injunction would bolster the illicit market.
Then, a funny thing happened on the way to the courthouse.
On February 29, 2024, Valencia’s local counsel got some help. Two attorneys from the Pacific Legal Foundation (PLF) entered appearances as co-counsel on plaintiff’s behalf. On Friday, the team from PLF asked to have the Motion For A Temporary Injunction taken off the Court calendar.
For those unfamiliar with the Pacific Legal Foundation (PLF), it is generally known as a powerhouse litigation group supporting libertarian and conservative causes. As of 2022, PLF has litigated 19 cases before the United States Supreme Court, won 17, and lost 2.
Its practice has been focused lately on challenging race-based preferences. It filed a lawsuit last month challenged Alabama’s racial quota on the Real Estate Appraisers Board where the State off Alabama sets aside two seats on its Real Estate Appraisers Board for racial minorities. It has filed lawsuits around the country challenging diversity set-asides and quotas.
In New York City, PLF is fighting policies that adversely impact Asian high-school students in admission to preferred schools because of social equity set-asides.
It fights race-based quotas and challenges laws giving preferential treatment to minorities. In fact, the Foundation is known for challenging minority set-asides and quotas that adversely impact non-minorities or that set up systems for racial quotas.
While PLF has not disclosed its strategy going forward in the Valencia case, it is fairly certain that it will mount a vigorous legal challenge to New York’s SEE policies in granting cannabis licensing preferences.
This is now the case to watch.
Potency Tax Repeal?
March 11, 2024 – New York’s controversial “potency tax” on cannabis products is likely to be repealed in the state budget as Gov. Kathy Hochul and the state legislature figure out how to best replace it with a flat excise tax.
According to the Albany Times Union, sources in the Senate and Assembly said their “one-house” budgets, due next week, both have policy language to repeal the potency tax, which industry stakeholders have said is also damaging legal retail sales and has driven more consumers to buy cannabis from unlicensed vendors who are not collecting or paying taxes.
Governor Hochul’s proposal would replace the potency tax with a wholesale excise tax of 9 percent, which would be in addition to the state and local retail sales taxes of 9 and 4 percent, respectively.
A Senate proposal would repeal the potency tax and replace it with a flat-rate 7 percent tax, which is similar to how alcohol products that vary in potency are taxed.
Whatever the ultimate tax rate, it seems that the potency tax is on the way out.
Will (And When Will) Cannabis Events Take The Place Of Growers’ Showcases?
March 11, 2024 – We may have to wait some time for the release of regulations governing the reincarnation of Growers’ Showcases as Special Events, but word is that rules are being considered for publication, public comment, and adoption some time in the next few months. Regulators are not known for swift work on regulations.
Growers’ Showcases were instrumental in relieving the backlog of product in cultivators’ inventories late last year when there were only a handful of open licensed dispensaries and dozens of showcases operating.
Now, with 78 dispensaries open, and more set to open soon, there is less pressure to pass regulations allowing cannabis events. What these Special Events will look like is anyone’s guess right now, but any opportunity for increased sales will presumably be welcome especially in those areas of the state with minimal retail options.
Opportunity Knocks! Community Reinvestment Grant Funding
March 4, 2024 – Last week, we explained that after the costs of administering MRTA, and costs related to training, and implementing incubators and workforce development for social and economic equity applicants, 40% of the tax revenue is dedicated to Community Grants Reinvestment Fund (CGR Funds).
The funds go to qualified community-based non-profit organizations and local governments to support several different community revitalization efforts, including, employment, adult education, mental health treatment, housing, financial literacy, and a litany of other programs assisting adults and children.
Last week, the Cannabis Advisory Board (CAB) convened its first meeting of 2024 to discuss the Community Grants Reinvestment Fund (CGR Fund).
The CAB is a multidisciplinary group of experts, comprised of 13 voting members appointed by the Governor, New York State Senate, and Assembly, and supported by a range of context experts from various agencies from across New York State.
The CAB is also tasked with governing and administering the CGR Fund which reinvests tax revenue from cannabis sales to those communities disproportionately affected by past cannabis prohibition policies.
The money in the CGR Fund will be administered and disbursed by the Office of Cannabis Management to provide grants for qualified community-based nonprofit organizations and approved local government entities to reinvest in communities disproportionately affected by past federal and state drug policies.
With New York topping $180 million in total cannabis sales in 2023, the CAB will soon be able to begin issuing these grants from the CGR Fund to community-based nonprofits and local governments. The Community Grants Reinvestment Subcommittee meeting furthered the discussion of how the CAB will decide who to issue these grants to.
Building on this momentum, the CAB has proposed a tentative timeline to establish goals for the implementation and distribution of the first funds in the CGR Fund:
- Mid-April: Public announcement of the CGR Fund opportunity and anticipated release date for the Request for Applications (RFA). Those interested in learning more about this opportunity shall register with the New York State Contract Reporter (https://www.nyscr.ny.gov/) to receive updated notifications on available opportunities. Nonprofit organizations must also be prequalified to receive awards and may visit https://grantsmanagement.ny.gov/get-prequalified to learn more about registering early.
- Early June: Goal to release the RFA, allowing applicants to start the application process.
- October 1st: Projected deadline for applicants to submit their applications.
- November/December: Anticipated Announcement of the awardees, culminating the selection process for community-based nonprofits and local governments.
Critics of this schedule have asked the same questions you are probably asking: Several years into cannabis sales and no grants have yet been awarded? And, the second question: Why no awards until November/December? Should it really take the better part of a year to get this program going? It looks like tax revenue collected from 2023’s sales won’t reach community-based organizations until early 2025 — at best.
New York awards 110 more adult-use marijuana business licenses
February 18, 2024 – It’s the event that we’ve all been waiting for: the first round of issuance of new licenses from the application window opened last year. At its last meeting, the Cannabis Control Board, voted to issue twenty-four cultivator licenses, nine distributor licenses, twenty-six microbusiness licenses, twenty-five non-provisional adult use retail licenses, and 13 provisional retail licenses.
The approvals mark the first round of non-conditional licenses issued by the state.
On Friday, the governor celebrated the board’s issuance of non-conditional licenses.
“Adult-use cannabis is a growing industry in New York that will help local economies across the state,” she said. “The approval of over 100 licenses is a good start and provides individuals with the opportunity to apply for licensing to help drive up local economies around them.”
[Congratulations to all of the successful applicants and awardees, and a shout-out to Rockland County-based Highland Gallery, LLC, a soon-to-be-open retailer in the Village of Piermont.]
Keep in mind that it may still take some time for some of the licensees to open their doors as there are likely still local municipal rules and inspections that need to be completed, depending on their jurisdictions.
For a complete list of licensees, click here.
2100 applications were received in the last round for what has been announced to be 250 licenses.
Some good news: New York retailers have recorded at least $174 million in legal cannabis sales, according to OCM figures released Friday.
New York Regulators Approve Marijuana Home Grown Rules
February 18, 2024 – Rolled over from the canceled meeting last month was consideration of rules allowing the home cultivation of recreational marijuana. At last week’s meeting, proposed rules were approved, but the approved resolution also starts a 60-day public comment period before the rules are finalized.
The regulations would allow anyone 21 or older to grow up to six plants for personal use, only three of which could be mature at one time. A residence with multiple adults could have a maximum of 12 plants, and people could possess up to five pounds of marijuana derived from the plants.
The six allowed for individuals include three mature and three immature plants. An immature plant is one that does not have visible flowers or buds.
For those who transform the flower to a concentrate, the limit on how much of that substance they can possess will be the equivalent of what the product would represent in weight from cultivated cannabis.
The rules also include a provision allowing licensed retailers to sell starter plants. The proposal was designed to give licensed retailers another vehicle to generate revenue. Retailers intending to sell starter plants will be required to have an active nursery dealer registration certificate from the New York State Department of Agriculture and Markets. Plants must be labeled with information that includes the strain, expected date of harvest and a warning to keep it out of the reach of children.
Cannabis officials on Friday said that their research indicates the ability of New York residents to grow their own marijuana should have a minimal impact on the licensed retail industry.
Marijuana seeds have been legally sold in the U.S. since 2018 under the federal Agriculture Improvement Act. The state Office of Cannabis Management does not regulate the sale of seeds and anyone 21 or older can purchase them online or at cannabis retail shops.
Landlords May Face Civil Forfeiture Of Real Property For Allowing Illicit Retail Operators
February 18,2024 – Readers of this newsletter know that we’ve been advocating for an amendment to the MRTA that would allow “in rem” actions against real property that is knowingly used to house illicit cannabis retail sales. The idea is that if a property owner or landlord knew or should have known that its tenant was operating an illicit retail outlet, the real property could be subject to civil forfeiture.
Last week, an Assembly bill was sent to the Economic Development Committee for review. The bill is titled, “The SMOKEOUT Act, (Stop Marijuana Over-Proliferation And Keep Empty Operators of Unlicensed Transactions” (Okay, doesn’t really flow off the tongue).
The SMOKEOUT Act does just that – Section 455 allows for the taking and forfeiture of real property utilized in the illicit sale of cannabis and cannabis products. Unfortunately, the Act also allows a defense where the property owner establishes by a preponderance of the evidence (more likely than not) that the use of the real property was not intentional on the part of the owner.
Obvious questions will arise as to what duty of investigation a property owner has. Can it turn a blind eye to the use? Will it have an affirmative obligation to determine and monitor how its property is being used. Do tenant uses like “smoke shop” and “paraphernalia” sufficiently put a landlord on notice that the use may be suspect? Can the property owner insulate itself from forfeiture by using a property manager or leasing agent between it and the tenant?
All of these issues should be worked out, but as before, we suggest the duty to keep illicit operators out of retail should fall on the property owner, and an affirmative duty to investigate the use of the property and the risk of loss should fall squarely on the property owner.
The Senate version of the SMOKEOUT bill is currently in Investigations and Government Operations Committee.
New Lawsuit Challenges Licensing and Fee Schedule Advantages For Women and Minorities; Claims White Men Denied Equal Protection
January 25, 2024 – A lawsuit filed yesterday in the United States District Court for the Northern District of New York challenges the advantages given to women and minority applicants in retail licensing by the Office of Cannabis Management. The plaintiff, Valencia AG, LLC, based in Jamesville, NY is owned by “males of light pigmentation who might best be described as Caucasian or white men,” according to the complaint. Valencia filed an application with OCM on October 12, 2023 seeking a microbusiness cannabis license. Not falling into any of the categories for SEE status, Valencia was unable to request any sort of priority status in its application.
Believing that priority would be given to applicants that attested they either owned or rented space that was immediately ready to open, and relying on representations made by OCM, plaintiff leased a storefront for $2,000 per month, plus utilities and insurance.
In January, when OCM published it list of the hierarchy of applicants based on the “randomized,” but prioritized and weighted selection of applicants, plaintiff ranked 2,042 out of about 2,200 “operationally-ready” applicants. Based on statements made by OCM, plaintiff believes it is unlikely that it will have its application reviewed or receive a license.
The complaint alleges that the preference or priority given to women and minorities, over white men, violates the Equal Protection Clause of the United States Constitution. Plaintiff also charges that the higher application fees paid by white men over women and minorities also violates the US Constitution.
For relief, Plaintiff asks for: (1) a preliminary and permanent injunction against the preferences given women and minorities; (2) a prohibition against OCM from processing any applications for cannabis licenses where those applications claim SEE status based on women or minority ownership; (3) the revocation and cancellation of licenses granted to SEE status licensees when based on women or minority ownership; (4) a refund of the higher application fees paid by applicants unable to claim SEE status based on women or minority ownership; and (5) a prohibition against the differing fee schedules based SEE status.
The case was assigned to US District Court Judge Gary L. Sharpe, Case No.: 5:24-cv-00116-GLS-DJS. Plaintiff is represented by Robert Purcell, Esq., of Syracuse, New York.
New Jersey Opens Doors To Cannabis Lounges – Sets Rules
January 28, 2024 – New Jersey Cannabis Regulatory Commission (NJ-CRC) finalized regulations to allow marijuana consumption lounges statewide. The regs are set to be published next month.
Here’s how the “social use” licenses will work:
- Consumption lounges cannot sell food or alcohol, but adults 21 and older could their own bring food or have it delivered if the local government code allows it;
- A consumption area must be attached to a dispensary, customers must be at least 21 or older;
- Food trucks will be allowed, if provided for in the local municipal code;
- Medical cannabis patients would be able to bring their own marijuana products;
- A business would be limited to owning one social use license;
- Microbusinesses would pay a $1,000 fee for a “consumption area endorsement” and standard businesses would pay $5,000;
- The application process hasn’t opened yet, but according to NJ-CRC Chief Counsel Christopher Riggs, the application portal for prospective licensees will open soon; and
- There will also be an exclusivity period (length of time unknown) for social equity and diversity licensees before other social use licenses will be awarded.
Adding the consumption lounges are expected to generate additional fees and tax revenue for the state.
On top of that, the commission also approved 70 new adult-use cannabis licenses, including retailers, manufacturers, cultivators and delivery services, positioning the state to see more than $1 billion in cannabis sales in 2024.
OCM Establishes A Randomized Queue For Reviewing Adult-Use License Applications
January 15, 2024 – Random generally means “made, done, happening, or chosen without method or conscious decision.” Is it destiny or fate, or just the luck of the draw? Well, for the 2,000-plus applicants that applied between October 4th and November 17th for Non-Provisional Adult-Use Retail and Microbusiness, the random sequencing used by OCM establishes their place in line to have their applications reviewed.
According to OCM, “The random queuing process was audited by an independent third-party to ensure it was random and unbiased.
Keep in mind that the queue order doesn’t indicate that order in which licenses will be issued, if at all, just the order in which the applications will be reviewed.
For brevity, and space, here is a list of the first page of applicants. For the entire list, click here to see where applications in your area fall out.
Hochul Vetoed Law Allowing Growers To Sell Surplus To Tribal Retailers
January 15, 2024 – Gov. Kathy Hochul (D) vetoed legislation at the end of December that would have allowed New York cannabis cultivation licensees to temporarily sell surplus cannabis to tribal retailers, as the state continues to struggle with a long-delayed market and limited number of dispensaries.
Readers of this newsletter may recall that one proposal to aid growers with surplus inventory was to temporarily allow sales to tribal retailers who operate under a different set of laws as Adult-Use dispensaries. Those hopes were dashed by Governor Hochul.
With the continue, but slow rollout of licensed dispensaries, growers will have additional outlets to sell inventory. But with sunsetting of Growers’ Showcases and the inability to sell to tribal retailers, growers will continue to struggle with existing and new inventory until New York has enough retailers to absorb past and present crops.
Multistate Operators Slow To Take The $5 Million Plunge
January 15, 2024 – PharmaCann is the only medical operator to open a co-located store in the state.
Although six cannabis multistate operators were approved by New York regulators to open retail shops, only one has so far taken the plunge.
The New York Office of Cannabis Management confirmed that as of Jan. 5, only Chicago-based PharmaCann had paid the required $5 million retail license fee and opened a joint medical-recreational location in Albany, which does business as Verilife.
The other five MSO’s that are eligible to open dual medical-recreational shops are Columbia Care NY LLC, Curaleaf NY LLC, Etain LLC, NYCANNA LLC, and Valley Agriceuticals LLC.
To open, MSOs will have to pay $5 million to the state for new adult-use cannabis retail locations. Each retail licensee – including the multistate operators – will ultimately be allocated three locations.
Speculation is that until New York’s illicit market is tamed, the $5 million entry fee makes the New York retail market less appealing.
Here’s The Skinny On Cannabis in New York State
January 7, 2023 – OCM issued its 2023 Annual Report. Here are some highlights:
- Adult-Use sales are expected to top $150 Million in 2023, with $137 million recorded as of December 9th.
- The state has 46 operational adult-use dispensaries opened and operating.
- State regulators granted 6,200 licenses, permits, registrations and provisional approvals in 2023 and 2024, according to the OCM. This includes 279 adult-use conditional cultivator licenses, 40 adult-use conditional processor licenses, 463 conditional adult-use retail dispensary licenses, 5,404 cannabinoid hemp licenses and permits, and 10 approved medical cannabis organizations, which are called registered organizations (ROs) in New York.
- The OCM received 6,934 total applications: 538 from processors, 372 from cultivators, 351 from distributors, 1,349 from microbusinesses and 4,324 from retailers. Of the applications received, 3,826, or more than 55%, were from social equity applicants.
- OCM officials has released a map that identifies the communities deemed disproportionately impacted by past cannabis enforcement (Loads Slowly). Approximately 25% of New York’s population experienced 75% of the arrests over the last four decades.
- The OCM indicated that it has provided training and mentorship to up to 300 conditionally approved retail licensees, as well as 241 legacy growers and processors, traditional farmers, and food and beverage manufacturers.
- The OCM’s Social & Economic Equity Team trained and engaged more than 60 Technical Assistance Providers (TAPs) to offer support to more than 700 equity applicants who sought assistance.
- Regulators also announced that the OCM is offering up to $50,000 in grants for eligible TAPs to support their efforts to help applicants in the recent application window.
- The OCM has also hosted more than 17 Cannabis Equity Roundtables to present the Social & Economic Equity Plan to advocates, municipalities, elected officials and interagency working groups.
- Regarding New York’s medical cannabis program, the state has more than 121,900 registered patients.
- Officials said they have seized 11,600 pounds of unregulated products, worth approximately $56 million street value. Officials have performed 369 enforcement inspections of unlicensed cannabis operations.
- Dispensary sales rose month by month throughout 2023. Adult-use cannabis sales grew from $2.2 million in January to $18.8 million in November.
- Adult-use dispensaries carry roughly 550 locally grown strains.
End Of A Good Thing — Cannabis Growers Showcases Sunset December 31st
December 11, 2023 – New York’s Office of Cannabis Management made an unexpected announcement on Friday and dealt a fatal blow to the state’s small contingent of craft growers who received a lifeline through Cannabis Growers’ Showcases (CGS).
OCM announced the successful Cannabis Growers Showcase program would be scrapped by year-end – over the objections and contrary to the wishes of cultivators.
The showcases, which range from farmers market-like setups to pop-up tents to more conventional retail experiences, were designed to help marijuana cultivators sell off the glut of inventory left over from last year’s growing season. The showcases generated more than $4 million in sales this year, or just under 4% of the total retail cannabis sales generated so far in 2023.
The showcases broadened the availability of cannabis products throughout the state and enabled buyers to purchase cannabis products in areas where no retail outlets were open, and where none could open because of litigation that stalled the opening of new retail outlets.
“There’s not enough distribution for small farmers,” Wyatt Harms, the co-founder and CEO of Brooklyn-based pre-roll brand Flamer, told MJBizDaily. He added “that many invested their life savings into legal marijuana. I don’t know why you would stop a program that is providing at least some relief to the farmers.”
With only a few weeks left in the CGS program, a new application has been filed for two pop-up showcases in Rosendale (Ulster County) in the former Esso gas station and Stone Krafters building at 2223 Route 32.
If approved, the showcases would be held on December 22nd through the 24th and again on the 29th through the 31st. The promoters expect about 200 customers arriving each day with half-hour entry slots available.
Two New Retail Dispensaries Open In Capital Region
On Friday, the Office of Cannabis Management said 31 adult-use stores are now open statewide.
Two newly opened retail dispensaries in the Capital Region include:
420 Bliss opened December 7th at 740 Hoosick Street in Troy. According to New York State, 420 Bliss is owned by Al Attoh, Renee Lindo and Gregg Little, entrepreneurs with experience in the retail, real estate, construction and the music business.
Capital District Cannabis and Wellness, 997 Central Avenue in Albany, opened December 8. The dispensary is owned by Capital Region natives James Frese and Pasha Adams, who bring to their enterprise diverse backgrounds in the restaurant and real estate industries.
The new dispensaries are supported by the New York Cannabis Social Equity Investment Fund. The fund was created to provide opportunities for those impacted by the inequitable enforcement of cannabis laws.
Six New Registered Organizations (Multi-State Operators) Receive CCB Approval
The CCB, at its meeting Friday, approved the following six registered organizations for adult use retailing:
- Columbia Care NY, whose parent is New York-based MSO The Cannabist Co.
- Curaleaf NY, part of New York-headquartered MSO Curaleaf Holdings.
- Etain Health, owned by RIV Capital, a Toronto-based investment firm.
- NYCanna, part of New York-headquartered MSO Acreage Holdings.
- PharmaCann of New York, whose parent is Chicago-based MSO PharmaCann.
- Valley Agriceuticals, whose parent is Chicago-headquartered MSO Cresco Labs.
In June, New York’s Office of Cannabis Management proposed allowing ROs/MSOs to enter the recreational retail market by year-end, reversing itself on the promised three-year waiting period for the state’s 10 vertically integrated medical marijuana providers.
The original roll-out provided a first-to-market advantage for social equity applicants and smaller suppliers by requiring the larger ROs to wait three years before competing. CCB scrapped that plan as it recognized the need to expand licensed and taxed retail availability in the face of thousands of unlicensed marijuana outlets that flooded the market statewide.
Other states, like Maryland’s relatively recent launch of adult cannabis, allowed ROs/MSOs access on day one of opening the adult market without incident.
Besides, whatever first-to-market advantage that existed was stalled and effectively derailed as approvals for hundreds of Conditional Adult-Use Retail Dispensary (CAURD) applicants and licensees were delayed for months because of lawsuits over the licensing process and social equity provisions that gave priority to justice-affected applicants over disabled veterans, distressed farmers, and women and minority owned businesses.
The ROs should open their doors to adult-use retail sales on or around December 29th.
Stipulation And Order Of Settlement Submitted To Court – Clock Starts On Acceptance
November 28, 2023 – The long-awaited “Stipulation And Order Of Settlement And Dismissal” was filed with the Court this morning. For the 426 CAURD applicants caught up in the litigation and unable to advance their applications or open retail outlets, any relief is good relief, provided it includes lifting the injunction issued back on August 7th by Justice Kevin Bryant.
The settlement stipulation hangs on the Court accepting its terms and dissolving the Preliminary Injunction within 10 business days of presentation to the Court, with an allowance for an agreement to extend the time should the court not feel bound by the time frame imposed by the Stipulation.
No consideration is given for a modification of the terms of the injunction – it seems like a take it or leave it offer, and the terms specifically say that the failure to dissolve the preliminary injunction renders all of the other provisions of the Stipulation and Settlement null and void.
The Stipulation settles all of the claims between the parties, with each side paying its own costs and attorney’s fees. In exchange for the dismissal, OCM will issue one adult-use dispensary license to each plaintiff and take whatever other steps are necessary to allow each plaintiff to become “fully operational.” Each plaintiff will also get “site protection” for the sites submitted.
Part of the bargain struck precludes OCM from issuing and “new or additional provisional” CAURD licenses until April 1, 2024, purportedly to allow OCM to focus and dedicate itself to process the pending applications and licenses.
Another provision of the agreement establishes a requirement that OCM work with the Division of Service-Disabled Veterans Business Development to ensure that participants in that program can avail themselves of opportunities in the cannabis market.
And, to prevent similarly situated potential plaintiffs from relying on this settlement to secure their own licenses, the language declares the settlement has no “precedential value” and not binding beyond this agreement.
Enforcement of the terms of the agreement are only available to the disabled veterans for 30 days from entry of an Order accepting the Stipulation (with a few extra days to cure). Within that window, an aggrieved party can move the court to compel enforcement of the terms of the stipulation. After that window closes, enforcement becomes an open issue.
So, just like in the Variscite case, OCM avoided the complicated legal and constitutional questions by awarding licenses to complainants instead of addressing the underlying problems with the implementation of the laws and regulations applicable to the agency. But what about the distressed farmers, minority and women-owned businesses and other disabled veterans who were not parties to the litigation?
Justice Bryant issued the temporary injunction because the implementation of the awarding of licenses ran afoul of the law – not just for the four plaintiffs, but for any applicant similarly situated. Yes, it’s true that there was no effort to establish a “class” for a class action suit, and giving away four licenses to set over 400 applicants back on track may seem like a small price to pay, but either the scheme awarding licenses was legal or it wasn’t. Justice Bryant said it wasn’t.
For the next few days, perhaps longer, we will see just how Justice Bryant views the stipulation and settlement. Perhaps he has a longer, more expansive view of the legal issues, or perhaps he will defer to the litigants. Either way, we will know very soon.
View the Stipulation and Order Of Settlement and Dismissal here.
Find a Cannabis Growers’ Showcase Near You (As of December 2, 2023)
“Settlement In Principle” Reached In Disabled Veterans’ Litigation
November 20, 2023 – New York regulators and a collective of disabled military veterans who challenged the state’s adult-use marijuana licensing process in state court have reached “an agreement in principle to settle this matter,” according to correspondence from Plaintiffs’ Counsel filed with the Appellate Division, 3rd Department, New York State.
The agreement announced Monday between the New York Cannabis Control Board and plaintiffs is likely to lead to the end of a temporary injunction that’s been in place since August as well as render moot motions for summary judgment pending before the Supreme Court.
The injunction, put in place by the New York State Supreme Court Justice Kevin Bryant, stalled the issuance of more than 400 conditional adult-use retail dispensary (CAURD) licensees across the state, and prevented the opening of licensed dispensaries for months.
The lawsuit, Carmine Fiore v. New York State Cannabis Control Board, filed by a cohort of disabled veterans, charged that the OCM overstepped its authority under New York’s 2021 legalization law – the Marijuana Regulation and Taxation Act (MRTA) – when it opened the licensing application window first to those with cannabis-related offenses and their immediate family rather than allowing other similarly situated applicants – disabled veterans, distressed farmers and women and minority-owned businesses to apply at the same time.
The agreement still must be finalized by all parties, including the state Cannabis Control Board and Justice Bryant, according to court documents.
During the pendency of the litigation, the New York State Supreme Court allowed a few exceptions to the injunction. Applicants caught up in the legal morass were left in a sort-of legal limbo, waiting on the sidelines while incurring financial losses from rent payments, legal fees, and other obligations they were obligated to meet.
The “agreement in principle” is happening at a time when New York has opened its application process broadly, with thousands of new applications expected during the open-application period.
The court delays from various suits likely contributed to the proliferation of illegal retail outlets across the state – some estimates put the number of illicit operations in the thousands, despite New York’s efforts to crack down on unlicensed sellers of cannabis products.
Tax Relief For NYC-based Cannabis Businesses
November 20, 2023 – Governor Kathy Hochul has signed legislation that provides income tax relief to New York City marijuana businesses that are currently prohibited from declaring business expenses as federal deductions under an Internal Revenue Service (IRS) code known as 280E.
Hochul signed it into law on Friday.
While Hochul signed a separate bill last year that included provisions allowing state-level cannabis business tax deductions, New York City has its own tax laws that weren’t affected by the state-wide change. The new measure is meant to close that gap and provide relief for New York City-based businesses.
“This bill would allow a deduction for business expenses, incurred by taxpayers authorized by the Cannabis Law to engage in the sale, distribution, or production of adult-use cannabis products or medical cannabis, for purposes of the unincorporated business tax (UBT), the general corporation tax (GCT), and the corporate tax of 2015, commonly referred to as the business corporation tax (BCT),” a summary of the law says.
The city’s tax code would be amended to add sections allowing the deductions “in an amount equal to any federal deduction disallowed by section 280E of the internal revenue code.”
“This modification to income is appropriate because, while the expenses of cannabis-related business cannot be deducted for federal purposes, New York law permits and encourages these businesses akin to any other legitimate business occurring in the State,” a memo attached to the bill says. “The City’s business taxes should similarly encourage these business activities.”
Other states have pursued similar income tax workarounds. Marijuana tax reform legislation at the federal level is stalled, leaving state-licensed cannabis businesses with significantly higher federal effective tax rates than similarly situated businesses.
The governor of New Jersey signed legislation in May to allow licensed marijuana businesses to deduct certain expenses on their state tax returns as a partial IRS 280E fix.
Multistate Operators (Registered Organizations) Gain Entry To New York Cannabis Marketplace
November 6, 2023 – To the joy of many, and the chagrin of others, New York is expanding medical cannabis retail licenses to large multistate operators.
The application window for “registered organizations” opened October. 31 and will run until 5:00pm December 19, according to a notice from state’s Office of Cannabis Management (OCM).
Registered organizations will pay a premium to enter what many refer to as the nation’s most untapped retail marketplace. New York, nearly two years after launching adult use sales has just 27 fully-operational licensed adult-use retailers in the entire state, about one outlet for every million New Yorkers.
The entry price is steep. Applicants must submit: (1) a nonrefundable application fee of $10,000 before the application deadline; (2) a registration fee of $200,000 within 10 business days of approval; and (3) in lieu of a lease or secured property, a secured bond of $2 million.
OCM has not put a cap or limit on the number of RO licenses. Instead, the agency says it will “issue registrations based on the quality of applications received and market needs.” That statement is contained in a FAQ put out by OCM offering explanations and details of OCM policies with links to other relevant materials.
The early release of licenses to registered organization is a blow to the licensed and soon-to-be-licensed adult-use retailers as well as hundreds of Conditional Adult-Use Retail Dispensary (CAURD) licensees and applicants who have been trying to open stores for months while lawsuits drag on challenging the very framework of license issuance in the state.
In September, the OCM voted to allow the state’s 10 medical marijuana operators to apply for adult-use retail licenses, essentially reversing its policy to ban MSOs entering the recreational market for the first three years.
OCM plans to protect the RO’s trade secrets and confidential information from New York’s Freedom of Information Law requests made by the general public and likely competitors by asking the ROs to identify which areas of the application they wish to be redacted as exempt from disclosure.
And, the guidance says that ROs that submit applications earlier within the application window will not have an advantage over applications submitted later. All applications must be submitted by the December 19th deadline.
Senate Subcommittee Meeting Discusses Flaws in Cannabis Rollout
November 6, 2023 – Last Monday, members of a New York Senate committee heard from witnesses and discussed legislative solutions to the state’s ongoing cannabis legalization implementation rollout and related problems.
The Senate Cannabis Subcommittee is chaired by Sen. Jeremy Cooney (D), who said, “The goal of the hearing today is to provide an opportunity for stakeholders across the adult-use retail cannabis space to raise concerns and to offer constructive feedback regarding the current cannabis landscape in order to foster a more robust and equitable recreational adult-use cannabis marketplace in New York.”
Chris Alexander, Executive Director of the Office of Cannabis Management (OCM), along with other officials with OCM, testified at the hearing.
Alexander assured members that state regulators are working to address concerns with what some refer to as the state’s cannabis legalization rollout failure. He recognized that delays related to various lawsuits and pending litigation have had a “significant impact on the rest of New York’s adult use cannabis supply chain.”
“Small farmers who are already distressed were left with no outlets for their product and have experienced significant financial hardship and uncertainty as a result,” he said. “We still have a long way to go before we can claim that the supply chain is functioning as intended.”
Supply chain issues were also raised by Senate Agriculture Committee Chair Michelle Hinchey (D) who said she and other lawmakers have been “sounding the alarm since the middle of the legislative session earlier this year on the crisis that’s happening right now for our cannabis farmers to effectively very little to almost zero response.”
Hinchey referred to legislation that was passed by lawmakers and is awaiting the governor’s action, the Cannabis Crop Rescue Act. It would allow licensed marijuana producers to sell products to tribal retailers, which Hinchey said is an example of how the legislature is seeking to ameliorate the issue.
Lawmakers and regulators discussed the state’s THC potency tax, illicit market enforcement efforts, licensing distribution priorities, preventing youth from accessing cannabis, and laboratory testing practices.
Additional governmental witnesses included representatives of the Cannabis Advisory Board, Dormitory Authority of the State of New York (DASNY), New York State Department of Taxation & Finance, New York City Council and New York City Sheriff’s Office.
Watch the New York Senate committee marijuana hearing in the video below:
Powerhouse Lawyers Take On Federal Government’s Interference With Legal Cannabis
October 29, 2023 – Finally, a suit filed in the United States District Court for the Western Division of Massachusetts against Merrick Garland in his capacity at United States Attorney General by a group of cannabis growers, processors, transporters and retailers from Massachusetts sets the stage for the undoing of the part of the Controlled Substances Act that makes participation in state cannabis programs a federal crime.
Filed by powerhouse lawyers at Boies, Schiller and Flexner on October 25th, the lawsuit details the obstacles that legal cannabis businesses face based on what the suit describes as an archaic adherence to federal marijuana laws that are no longer applicable in a nationwide environment where 38 states, including the District of Columbia have legalized medical and/or recreational cannabis.
The suit describes a myriad of problems — denial of access to SBA loans and federal grants, denial of access to banking and credit card processing, denial of access to mortgages, loans and leasing opportunities, denial of access to payroll processing, denial to access to job fairs and training programs, unfair taxation and other difficulties — all caused by the federal government’s adherence to what the suit says is an unconstitutional exercise of federal authority.
Additional obstacles include denial of access to bankruptcy and trademark protections, complications with delivery to customers residing in federal housing or receiving federal housing support, and denial of federal farm benefits to farmers that lease even a portion of their fields for cannabis cultivation.
While the suit, filed in Massachusetts describes the difficulties of Massachusetts residents and businesses, the same obstacles are faced in New York and elsewhere and any relief afforded would likely be applied nationwide, or certainly to any state that adheres to the rigid controls in place in Massachusetts to keep cannabis out of interstate commerce.
The suit asks for relief in the form of declaratory judgments. First, that the CSA as applied to plaintiffs exceeds Congress’s authority under the commerce clause (regulation of interstate commerce) and the necessary and proper clauses. Second, declaratory relief that the CSA as applied to plaintiffs violates due process, that is by regulating cannabis in states where it is legalized, the federal government’s actions are unwarranted and unlawful.
The obstacles are real and this is the suit to watch going forward, though no temporary or permanent injunctive relief was requested. The SAFE Banking Act and rescheduling of cannabis may relieve some of the pressure on cannabis businesses, but would only have a limited impact on the problems created by the federal government’s adherence to the CSA.
The suit was filed in the Western Division of the United States District Court for the District of Massachusetts, Case No.: 3:23-cv-30113-KAR.
State Senate Subcommittee Meeting Studies Flaws in Cannabis Rollout
October 29, 2023 – All eyes are on the New York State Senate Subcommitee on Cannabis which is holding a public hearing, set for 11:00 October 30 at 11:00am, to discuss problems plaguing New York’s fledgling cannabis market.
The hearing, organized by Senator Jeremy Cooney, D-Rochester, who serves as the chair of the Subcommittee on Cannabis, will discuss the multiple lawsuits stymying the rollout of retail dispensaries as it relates to the State’s commitment to social justice goals, as well as the adverse impact on growers, processors and retailers.
Since passage back in 2021, the legal market for cannabis in New York has met a number of obstacles, both legal and logistical.
“As state lawmakers, we can’t just pass bills and hope they work out. Instead, through legislative oversight, we have the responsibility to work with our governor and state agencies to ensure our collective goals are met,” Cooney said. “Two years after legalizing adult-use recreational cannabis, New Yorkers are frustrated and disappointed in the state’s ability to launch a safe and legal marketplace. I am calling this hearing with my partners in the Senate because we believe New Yorkers deserve clarity on what has been done so far and how we can help the retail market going into the next legislative session.”
Licensing, has proven a challenge for the state. When New York first legalized recreational cannabis, it established the Conditional Adult-Use Retail Dispensary (CAURD) licensing program.
However, in recent litigation, New York Supreme Court Judge Kevin R. Bryant halted the approval of CAURD licensing for all of New York State, based on the priority given justice-affected applicants over other eligible licensees. The suit was brought by a group of disabled veterans who were supposed to have the same access to licensing as justice-affected applicants.
Bryant has since partially lifted the suspension, but only for about 30 licensees out of 463 given conditional approval. What’s clear to Cooney and his committee is that industry iprogress is pretty much at a halt, even with the opening of new applications and licensing options.
The October 30 hearing will also host the chairs of related Senate committees. The committee chairs of Agriculture, Finance and Investigations and Government Operations will all be attending. Additionally, testimony from cannabis growers, retailers and regulators will shine a spotlight on the flaws of the budding industry and hopefully discuss solutions.
This newsletter will update its readers on what happens at the committee meeting as soon as we are able.
New York’s Report Card on Dispensaries & Sales Show Comparative Weakness
October 23, 2023 – Let’s face it. New York’s rollout of legalized recreational marijuana dispensaries has not met the state’s expectations. Whether it was the federal lawsuit that challenged a system that preferred in-state applicants, or the state suit challenging the exclusion of disabled veterans as compared to justice-affected applicants, there have been a series, to be generous, of “speed bumps.”
But how bad has New York’s rollout been compared to other states and how have revenues met or fallen short of expectations. Remember that New York’s recreational market was expected to generate more than $1 billion per year in sales by 2025, and $4.41 billion by 2030, according to cannabis research firm New Frontier Data.
So let’s take a data dive at the numbers and see how New York is faring compared to other states that have legalized recreational marijuana. The analysis leaves off those states that had several years head start, and looks primarily at those states that legalized cannabis in 2019 or later.
New York passed MRTA in 2021. States like Maryland and Missouri passed their versions of legalized cannabis in 2022. Michigan with and Montana both had a head start over New York. But, New York has only 27 open dispensaries (as of this writing), while states like Maryland (which legalized cannabis in 2022) already have 101 dispensaries. Missouri, which legalized last year, has 214.
When New York State legalized recreational cannabis sales in 2021, the state predicted it at least 120 adult-use recreational dispensaries would be open by now.
Montana has 432 dispensaries. New Mexico has 633 – more than twenty times the number in New York.
But it’s not only the number of dispensaries that are behind expectations. Let’s take a dive at taxable sales, compiling the best numbers available.
In 2023, New York has pulled in about $66 million in taxable sales. Montana, with about 1/20th of the New York’s population has generated nearly $170 million during the same time period.
And, even though New York and New Jersey have about the same number of legally operating dispensaries, New Jersey has sold more than $305 million worth of recreational pot from its 29 dispensaries, four times New York’s sales. Connecticut’s sales eclipse New York’s by 50%.
Maryland stands apart. With legalized sales outlets first open in July, including allowing medical operators to sell recreational cannabis, it has generated $85 million in sales in the first month of opening dispensaries – more than New York has all year to date.
Critics say that New Yok has made a series of errors, including a flawed roll-out preferring justice-affected applicants, delay in allowing sales from medical cannabis operators, and a calamity in funding available to conditional licensees.
Others say despite these self-inflicted errors, New York sought to protect small operators from being overwhelmed by bigger, more experienced growers and sellers and that that was the right thing to do.
But these same stumbles have rendered New York’s legal cannabis cultivators unable to find buyers for a good part of last year’s crop, as well as this year’s.
New York is trying to make amends and get its cannabis industry back on track. Licensing is opened up broadly with thousands of applications flooding in. Medical marijuana firms will be able to to open adult-use stores this year and next.
Marginalized applicants will still receive some priority, with a lion’s share of the licenses in the general application pool going to them. New York is also fast-tracking applicants who can adequately prove they have control of a location (without contingencies) hoping to have more locations open soon.
All of these measures should help. Let’s take a look at these same metrics in mid-2024 and hopefully, New York’s nascent industry will be on a path to better meet its potential and expectations.
Adult Use Cannabis License Application Window Extended to December 18th
October 23, 2023 – The New York State Cannabis Control Board (CCB) voted to extend the adult-use cannabis license application window from December 4, 2023, to 5 PM EST Monday, December 18, 2023. This application window applies to all adult-use license types.
Additionally, the priority application period for non-provisional retail dispensary or microbusiness licenses where the applicant can demonstrate proof of control over a location, is also extended from November 3, 2023, to 5 PM EST on Friday, November 17, 2023.
Due to the uncertainty caused by the pending litigation challenging the validity of the CAURD program, provisional CAURD licensees have been notified of the opportunity to apply for an adult-use retail dispensary license during this application window.
Individuals with questions about the application process are encouraged to attend one of OCM’s “Roadmap to Adult-Use Application” events virtually or in-person to get real-time answers. These live sessions will provide insight and guidance on the application process.
Stay Pending Appeal Denied; Expedited Briefing Schedule and Calendar Preference Issued
October 16, 2023 – Many were surprised when the Supreme Court, Appellate Division, asked pointedly if the Cannabis Control Board’s Motion For A Stay of Justice Bryant’s Injunction was rendered moot by the opening of Adult-Use Licenses on October 4th. More surprising though was the response from the CCB and the Appellate Court’s Order denying the stay pending appeal. It seemed of little consequence to those awaiting relief that the Court agreed to a calendar preference (over other pending appeals) and an expedited briefing schedule. With briefing completed by November 3rd, perhaps a resolution of the matter is not far off.
Meanwhile, the CAURD licensees stuck behind the injunction continue to incur losses in time and money. Growers continue to lose access to retail markets. Processors the same. The opening of the licensing options on October 4th was good news for some, but to date only five licensees have secured relief from the temporary injunction.
Those fortunate few are Kush Culture Industry (Queens, NY), ConBud LLC (Manhattan), Air City Cannabis (Mohawk Valley), Gotham Buds, LLC (Manhattan), North Country Roots, Inc (North Country, Plattsburgh).
The license applications open as of October 4th include Adult Use Cultivators, Adult Use Processors, Adult Use Distributors, Adult Use Retail Dispensaries, and Adult Use Microbusinesses.
Applications for nursery, delivery, cooperative or collective, and on-site consumption licenses will be made available at a later date. Most municipalities in the state opted out of allowing consumption lounges in their jurisdictions.
The existing conditional adult-use dispensary or CAURD licenses are good for four years from the day issued. However, conditional cultivator licenses expire two years after issue and OCM is recommending those licensees start the transition (away from conditional) during the upcoming window.
The Office of Cannabis Management has sought to clarify the “Notice To Municipality” requirements for applicants applying for a retail dispensary or microbusiness license with retail authorization and made clear that OCM does not consider these types of applications filed until:
- the applicant provides proof of notification to the municipality;
- the applicant submits proof of control over the proposed retail dispensary location; and
- the proposed retail dispensary location receives a location determination from the Office as to whether the location meets the proximity requirements in the Cannabis Law and corresponding regulations.
In order to comply with Section 76 of the Cannabis Law, an applicant must have completed their notification to municipality 30 days before an application is filed with the Office.
OCM acknowledged some confusion and said, “Applicants intending to apply for a final license during the first 30-day application window have expressed concerns that they will not be able to meet the 30-day notice to municipality requirement and still be able to apply by November 3, 2023. In response, the Office is clarifying that the Office will not be making any location determinations on proposed retail locations submitted with an application on or before November 3, 2023 until at least 30 days following the closing of that application window. Accordingly, any applicant that applies with proof of control of a retail location (for a proposed retail dispensary or microbusiness with retail authorization) can upload their application on or prior to November 3, 2023, at 5:00PM, and still meet the notice to municipality requirement established by Section 76 .”
Applicants applying for a provisional license (without proof of control over a proposed retail location) can apply up until December 4, 2023 at 5:00PM. Applicants for a provisional license do not need to complete the notification to municipality at the time of initial application upload, since no location is associated with their application. Once a provisional licensee finds a location, they must complete the notification to municipality requirement in the same manner as an applicant applying with proof of control of a retail location.
Municipalities will each receive a minimum of 30 days (or 60 days if a 30-day extension is properly requested) to review the proposed location for the retail dispensary or microbusiness with retail authorization and be able to provide an opinion to the Cannabis Control Board (CCB) as required.
Clocks (or calendars) are ticking, and applications will likely number in the thousands.
October 4 Opens The Door To New Cultivators, Retailers, Distributors, Processors & Microbusinesses
October 2, 2023 – On Wednesday, New York state will begin accepting applications for new cultivators, distributors, retailers, processors and microbusiness licenses. Microbusinesses are allowed to cultivate and sell their own cannabis from a retail venue or farm stand.
Expectations are that the OCM will issue between 1,500 and 2,000 new licenses, though new guidance says 500-1000 retail dispensaries, 220 microbusinesses, 40 indoor cultivation licenses, 30 distributors and 155 processor licenses. For more details on guidance, click here.
“We’re expecting thousands of applications from folks all across the country who want to come and operate in what will be the best market in the world,” Chris Alexander, state Office of Cannabis Management Executive Director, said during an advisory board meeting last Tuesday.
So far, the state has issued about 700 conditional licenses, including 273 for cultivators, 40 for processors, 463 justice-involved and 10 not-for-profit retailers. But, fewer than two dozen retail stores are open to date because litigation over the priority given to justice affected applicants over disabled veterans and others has derailed the openings of new dispensaries.
On Friday, New York issued new guidance called “A Roadmap To Adult Use Applications.”
According to the guidance: “Starting October 4, applications for Cultivator, Processor, Distributor, Microbusiness and Retail Dispensary licenses will be available on New York Business Express (NYBE). All adult-use license applications must be submitted by 5:00 PM EST on Monday, December 4, 2024. The Office will commence its first and approval process for applicants who apply with control over a proposed retail dispensary or microbusiness location by 5:00 PM EST on Friday, November 3, 2023. The retail and microbusiness licenses applications will remain open to collect applications for provisional licensure until the 5:00 PM EST on Monday, December 4, 2023, deadline.”
“Applicants for a cultivator, processor, or distributor license must submit proof of location control to be considered in this application window. Applicants for a retail dispensary or microbusiness license who apply with proof of control over a location will be on track to go through the November 3rd approval process.
“With the mission of equity and access, the Cannabis Law establishes a goal to award 50% of all adult-use licenses to Social and Economic Equity (SEE) applicants including individuals from communities disproportionately impacted by the enforcement of the prohibition of cannabis, minority and women owned businesses, distressed farmers, and service-disabled veteran-owned businesses.
“Application and license fees are reduced by 50% for all qualified SEE applicants. In order to qualify for SEE status, sole control of the applicant must be held by an individual (or individuals) from the groups that qualify for SEE.
Proof of location control is generally thought to be ownership of a property, a fully-executed lease without contingencies. An open question would be a binding Letter Of Intent from a Landlord, but as this is not listed as “control” it is probably a better practice not to rely on an LOI, even if binding..
The licenses available include Adult Use Cultivators, Adult Use Processors, Adult Use Distributors, Adult Use Retail Dispensaries, and Adult Use Microbusinesses. Click on the links for an overview of each license type.
Additional license types, including nursery, delivery, cooperative or collective, and on-site consumption licenses will be made available at a later date. Most municipalities in the state opted out of allowing consumption lounges in their jurisdictions.
The existing conditional adult-use dispensary or CAURD licenses are good for four years from the day issued. However, conditional cultivator licenses expire two years after issue and OCM is recommending those licensees start the transition (away from conditional) during the upcoming window.
“This will not be the only time that conditional licensees can transition. We’ll open up another period for the transition before that license expires but we hope they will get it done now,” Alexander said.
Authorized Growers’ Showcases:
Bulk Sales To Tribal Nations May Offer Cultivators An Outlet For Unsold Cannabis
October 2, 2023 – A bill waiting for Governor Hochul’s signature could affect the fortunes of the many cultivators who have been unable to sell cannabis grown in the last season for want of retail outlets.
The law, if signed, will allow the bulk sales of cannabis to tribal retailers. The bill authorizes “conditional adult-use cultivator and processor licensees to sell tested, packaged, and sealed cannabis products or biomass to a cannabis dispensing facility licensed or permitted by a tribal nation for retail sale.”
Sixty-six members of New York’s legislature are urging Gov. Kathy Hochul to sign the bill that would allow licensed marijuana producers to sell products to tribal retailers. The law would provide much needed relief to the hundreds of cannabis farmers sitting on surplus product with less than two dozen open retailers to absorb the inventory and few growers showcases approved and scheduled.
“Right now, there are over 200 cannabis farmers trying to sell their crops but only 23 dispensaries open statewide,” the bipartisan Senate and Assembly members wrote in the open letter to Hochul on Monday. “This has resulted in more than 250,000 pounds of unsold cannabis. Farmers who took out loans and leveraged all their assets to cultivate these crops are demoralized and facing financial disaster unless we act quickly to provide them with an alternate market.”
Lawmakers want the governor to sign S.7295/A.7375, titled the “Cannabis Crop Rescue Act” and passed by the legislature in June.
The letter issued by the legislators cite, “regulatory delays, lawsuits, and logistical and financing challenges have caused the state to miss its timelines and targets,” and continues. “however, cultivators are the group paying the steepest price.”
“New York’s cannabis farmers, who went out on a limb to help get the state’s legal market off the ground, should not be facing financial ruin because of regulatory delays,” the group said. “We should be giving them every possible opportunity to stay afloat while they await the development of the market they were promised.”
“While lawsuits are being litigated and illegal stores are flourishing, NY’s cannabis farmers are suffering,” lawmakers said in the earlier statement. “Crops were grown last year with the understanding that there would be a legal market for them to sell it… We are urging the governor to quickly sign this short-term solution, one that will help provide some measure of relief to what is quickly becoming an agricultural emergency.”
A sponsor memo states that conditional cultivation licenses were originally issued “with the understanding that growers would not be permitted to sell their product outside of state lines, but that a robust state market would exist during the conditional license timeframe.”
“Due to a variety of circumstances beyond the control of New York’s cannabis farmers,” it continues, “many licensees are unable to sell their finished products or afford to process their cannabis.” As a result, “crops are losing potency, color, and terpene profile in storage, greatly reducing their value. Without the ability to sell their product, many are in severe financial distress and will be unable to afford to plant a crop this growing season.”
About 280 cultivators in New York currently have conditional licenses, which were initially offered to those already participating in the state’s hemp pilot program. Allowing growers and processors to sell to retailers licensed by tribal nations “protects New York’s cannabis industry, including distressed growers, to ensure a healthy local cannabis economy into the future,” the sponsor memo says.
Lawsuit by Third-Party Marketer/Aggregator Challenges New York Cannabis Regulators As Anti-Competitive
September 25, 2023 – It seems like New York State’s Cannabis laws were designed to prevent price competition among dispensaries and keep competitive pricing information away from the public.
Statements like, “We don’t want consumers comparing prices. We want them to go to their neighborhood” dispensary to buy cannabis, is the message fromOffice of Cannabis Management former chief of staff Axel Bernabe, according to a lawsuit filed by Leafly, a Delaware company based in Seattle.
The lawsuit, filed by Leafly and others challenges the barriers to entry in the nascent marketplace. The litigation basically challenges NY’s ban on third-party marketers and information aggregators that would compile pricing and other information for consumer comparison.
In New York, third-party marketers are allowed to compare alcohol prices and publish them, but not so for cannabis data aggregators.
A Leafly spokesperson called the ban “a misguided attempt to keep consumers uninformed and to restrict retailers’ ability to market and promote their products.”
To demonstrate harm and possibly avoid standing issues, Stage One Dispensary in Rensselaer, and an individual Leafly consumer in Erie County are also named plaintiffs in the suit, which calls New York’s adoption of the regulation arbitrary and capricious, and a violation of the U.S. and New York constitutions.
“New York’s Office of Cannabis Management has had every opportunity to build on the experiences of other states’ legal cannabis markets, and instead has chosen to adopt a set of misguided regulations that, in some key respects, unduly hamstring the state’s burgeoning cannabis industry,” Leafly said in a statement.
Small cannabis business owners already “face significant limitations in their ability to reach cannabis consumers.”
So far, after more than 2-1/2 years, only 23 retailer businesses have opened, but the state has committed to open applications broadly beginning Oct. 4 and running for sixty days thereafter, with no limitations on the number of applicants or licenses. It has also opened its market to out-of-state operators.
To prepare for the New York market, Leafly claims to have invested more than $300,000 and 500 hours to connect, strengthen, and grow New York’s cannabis industry. It says retailers rely on Leafly to provide a platform to connect with, and advertise to, consumers.
According to the lawsuit, the regulations banning Leafly’s marketing services are “inconsistent with the New York Cannabis Law, irrational, unsupported by the facts, and arbitrary and capricious. Even worse, these regulations violate Petitioners’ rights guaranteed by the United States and New York Constitutions.
Leafly says it operates in a manner akin to Open Table, an app that does not take payments and does not sell food, but nevertheless facilitates connecting consumers with restaurants through an online business model providing free publicly accessible information to turn a profit.
BREAKING NEWS! The New York State Office of Cannabis Management has filed a motion in the appellate court seeking a 60-day stay of Justice Bryant’s Preliminary Injunction. If granted, that time would allow it to continue to process CAURD applications. The major complication and confusion is that the October 4th opening for general licensing will occur before a decision on the stay is likely. Stay tuned…..
New Regulations From CCB Seek To Offer Clarity On General Non-Conditional Licensing
September 18, 2023 – A raft of new regulations was adopted by the Cannabis Control Board (CCB) last week that many hope will solve the ills that sidelined the 2-1/2 year old rollout of New York’s cannabis industry.
Some also believe that these new regulations will mitigate the complications of various lawsuits brought against the CCB, including the ones brought by medical marijuana sellers and disabled veterans – both of whom claim that the CCB’s rollout was in contravention of the plain language of the enabling law.
The new regulations outline licensing and operating procedures for the different segments of the cannabis industry. They provide for the licensing of eight types of businesses: plant nurseries, cultivators, processors, distributors, dispensaries, delivery services, microbusinesses and cooperatives.
As originally intended, the licensing divides out between suppliers and retailers, with a ban on entities holding stakes in the other to prevent market domination.
The new rules also offer some clarity on priority licensing for social equity and economic equity applicants and include distressed farmers.
Companies licensed to sell medical marijuana, after the payment of a $20 million fee, can enter the adult use recreational market as both retailers and wholesalers. Also, like a microbusiness, these companies can grow, manufacture and sell their own product.
The 300 cultivators and processors who have been operating under conditional licenses will be able to operate with a general, non-conditional license.
Pending will be additional guidance on completing applications and qualifying as a social and economic equity applicant.
Starting October 4th, applications will be accepted for 60 days. Application fees range from $750 to $300,000, with discounts available.
The regulations do not contemplate a cap on the number of dispensary licenses, though the New York Times recently referred to analysts who estimate up to 2000 dispensaries would be necessary to handle consumer demand.
One category missing from the new regulations is guidance on consumption lounges.
Not all commentators at last week’s meeting were happy about the acceleration of allowing medical cannabis companies to operate fearing that allowing these large corporations to operate would give them an unfair advantage and ultimately enable them to dominate the market.
Feds Consider Rescheduling Marijuana From Schedule I To Schedule III
Change would affect taxes, but not access to institutional banking.
September 8, 2023 – The Health and Human Services Department has recommended moving marijuana from a “Schedule I” drug to “Schedule 3” essentially reclassifying cannabis from a category of drugs deemed to have “no currently accepted medical use and a high potential for abuse” to a less regulated, but still controlled category.
No action has yet to be taken, and the decision will be made in conjunction with the Drug Enforcement Administration. A lengthy and public review process would follow, including opening a public comment period.
Schedule I drugs include heroin, quaaludes and LSD.
Schedule III drugs are still considered controlled substances and generally include ketamine, anabolic steroids and some acetaminophen-codeine combinations. Trafficking Schedule III drugs is still a federal crime. Producing, storing and selling Schedule III drugs requires prescriptions and intensive record-keeping and tracking.
The biggest benefit to the fledgling New York dispensary business relates to taxes. Under the federal tax code, dispensaries that sell Schedule I drugs cannot deduct rent, payroll or various other expenses that other businesses can write off. Without the ability to write off these expenses, licensed pot dispensaries can pay an effective tax rate of up to 70%. Illicit and unlicensed pot sellers that don’t pay income taxes have an unfair advantage over licensed sellers.
The ban against deducting business expenses doesn’t apply to Schedule III drugs, so the proposed change would cut dispensaries’ taxes substantially and level the playing field against illegal and unlicensed competitors.
That said, the reclassification from Schedule I to III doesn’t change the federal rules regarding banking where federal regulations deny dispensaries access to institutional banking. Those changes won’t come until the SAFE Banking Act passes in one form or another.
National Organization for the Reform of Marijuana Laws Deputy Director Paul Armentano said that reclassifying marijuana would be “perpetuating the existing divide between state and federal marijuana policies.”
Minority Cannabis Business Association President Kaliko Castille said rescheduling just ”re-brands prohibition.”
“Schedule III is going to leave it in this kind of amorphous, mucky middle where people are not going to understand the danger of it still being federally illegal,” Castille said.
Change comes slowly and in incremental steps.
Yet Another Lawsuit Seeks to Undermine New York’s Fledgling Cannabis Industry
Coalition equates state funding with money laundering.
September 8, 2023 – Not everyone is happy that recreational cannabis has been legalized in New York State.
Anti-cannabis groups — the Cannabis Impact Prevention Coalition and the Cannabis Industry Victims Seeking Justice, along with several individual plaintiffs – filed suit in federal court in Albany charging that New York’s $200 million dollar, state-established fund supporting social equity licensees is essentially “money laundering”.
The suit was filed against the Governor, the Cannabis Control Board, the Office of Cannabis Management and various officers and directors of those entities. The suit seeks declaratory and injunctive relief.
The suit takes a clever approach to shutting down New York’s cannabis industry. It charges that the Dormitory Authority of the State of New York (DASNY), a state agency which oversees the $200 million fund, is violating federal law due to marijuana’s status as a Schedule 1 narcotic.
“It is unlawful to knowingly open, lease, rent, maintain, or use property for the manufacturing, storing, or distribution of controlled substances,” the lawsuit claims. “DASNY normally finances, designs, and builds health and education infrastructure. Ironically, DASNY would instead become the biggest marijuana trafficking landlord in New York.”
“The taxes that the state collects from marijuana sales are the proceeds of marijuana trafficking,” the lawsuit states. “The fact that the state collects these proceeds as taxes does not magically cleanse them of their illegality.”
This is the second lawsuit filed by the coalition seeking to undermine New York’s legalization laws. The earlier suit was based on federal preemption, arguing that federal law making marijuana illegal trumps state laws that legalize it.
The effectiveness of the DASNY-managed fund has been a subject of much debate. DASNY has signed only twenty three leases for dispensary locations, and is negotiating sixty-one others.
Earlier this month, an injunction from a New York State Supreme Court temporarily derailed all retail licensing based on a finding that the CCB and OCM illegally gave preference to justice applicants over other social equity applicants, including disabled veterans and women and minority owned businesses.
In yet another lawsuit, filed in March, a diverse coalition of interested stakeholders demanded that state regulators open up universal licenses to multistate operators that hold medical marijuana licenses in New York. That coalition includes Acreage Holdings, Curaleaf, Green Thumb Industries, and PharmaCann.
Let’s just say that lawyers representing New York State, CCB and OCM have a lot of work to do to save what’s left of New York’s entry into the recreational marijuana market.
Court Reverses Itself And Shuts Down Any New Openings Of Dispensaries Pending Truthful Submission From Cannabis Control Board
September 1, 2023 – It seems like only last week (that’s because it was last week) that State Supreme Court Justice Kevin Bryant green-lit twenty-three dispensaries that were purportedly fully approved and ready-to-go to open, while holding off on seven others for further investigation.
Bryant made that ruling, based on the belief that the Cannabis Control Board (CCB) had accurately submitted the names of those entities that were ready-to-go. Turns out that the CCB’s most recent affidavit in the case admitted that “not all thirty applicants have met all licensing requirement” despite Justice Bryant’s clear instruction that only those licensees that “met all of the requirements for licensing, including but not limited to site plan approval from the CCB and where applicable from local municipalities” be submitted.
Something must have gotten lost in the translation, because despite further submissions by the CCB, Justice Bryant said that the additional information “still does not provide the clarity that is necessary for this Court to determine whether-or-not a particular licensee should be exempt.”
Bryant described the submission under oath by the CCB as containing “contradictory and confusing assertions that leave significant questions as to whether the licensees on the list have actually me all requirement.” What was not clear to the Court was whether any of the thirty identified licensees are actually fully approved and compliant with the Court’s order.
Based on clear frustration with the CCB’s submissions, Bryant re-imposed the preliminary injunction against all licensees and granted no exemptions — meaning no licensee may open until the CCB provides clear and unambiguous information regarding full approval, including site plan approval.
Needless to say, the licensees are in a twist. Many have made their own submissions to the Court to identify the hardships they face from the delays. Plaintiffs in the case — the four disabled veterans who have been denied access to license applications — objected to the individual submissions as unnecessary, encompassed by CCB’s submissions, and a potential cause of unnecessarily complicating the litigation.
Justice Bryant was as clear as he could be in his earlier ruling: the CCB illegally preferred “justice” candidates over the clear language in the enabling law which clearly required opening licensing opportunities to all social equity applicants at the same time, including disabled veterans, and women- and minority-owned businesses.
Another hearing is set for September 15th.
Court Allows 23 New Retail Licensees To Open; Holds Off On Seven Contested Applications; Halts Hundreds Of Pending Applications.
August 28, 2023 – State Supreme Court Justice Kevin Bryant is unambiguous about his ruling — New York State illegally preferred “justice” candidates over the clear language in the enabling law which clearly required opening licensing opportunities to all social equity applicants at the same time, including disabled veterans, and women- and minority-owned businesses.
In fact, Justice Bryant basically felt the entire licensing process used by CCB/OCM was flawed as the state legislature never actually created the Conditional Adult Use Recreational Dispensary (CAURD) category. It was a creation of CCB/OCM. The state did approve conditional licenses for growers and processors, but opted not to create a conditional dispensary license. This was essentially an “overreach” and an illegal “creation:of the CCB/OCM.
Despite these flaws, Bryant recognized that disrupting the entire licensing system and invalidating the existing licenses was a bridge too far. And, despite these clear breaches of the law, Bryant allowed the CCB/OCM to submit the names of applicants who had essentially met all of the requirements of licensing as of August 7th, including site plan approval from the CCB and zoning/planning approval from the relevant municipalities. CCB/OCM submitted 30 names of applicants it deemed having met those requirement.
Of those 30, only seven were challenged — mostly delivery-only locations and one where it was unclear it the site selected was suitable — allowing 23 new licensees to move forward and open. The Court will review the seven challenged applicants and likely make a decision soon about their status soon.
The 30 licensees submitted to the Court were:
New York’s First Round Of Approved Cannabis Growers’ Showcases
August 21, 2023 – New York State has approved several Growers’ Showcases to help ease the accumulation of inventory for growers with limited venues for selling, and to give licensed retailers a financial boost.
New York State is the first in the nation to allow the sale of cannabis at state and locally sanctioned locations. Learn more about the program here.
Judge Extends Temporary Marijuana Licensing Shutdown For Two More Weeks
August 11, 2023 – As it stands, drug felons have a preference over disabled veterans in New York’s nascent marijuana market. State Supreme Court Justice Kevin R. Bryant is considering leveling that playing field and extended a temporary injunction for an additional two weeks to allow the litigants to file legal briefs making their arguments or sort out a settlement.
On one side, the Office of Cannabis Management believes it is applying the intended concepts of social equity by opening conditional retail licensing first to individuals who have run afoul of the drug laws (or members of their immediate families). By giving them first dibs, OCM believes it is righting the wrongs of the past in overzealous policing and prosecution of the state’s drug laws.
On the other side, a group of four disabled veterans read the language of New York’s Marijuana Regulation and Taxation Act’s social equity provisions as putting them on the same ground as justice-affected applicants. They say the law does not give one “social equity” group – justice affected individuals — a higher standing or preference over any other “social equity” group, including disabled veterans.
In a preliminary injunction issued last Monday, the Court agreed with the disabled veterans.
The temporary order stopped all applications from being processed and put on hold all new retailers that have not yet opened their doors. On Friday, at a hearing in Kingston, Justice Bryant extended his order for two more weeks.
According to papers filed in the case, marijuana retail license applications will open for all applicants on October 4th.
A group of approved licensees also moved to intervene in the case, saying that even the two week extension may push them into bankruptcy.
OCM has settled litigation in the past rather than have a court rule against it. In April, OCM settled with an out-of-state applicant who claimed that New York’s program illegally favored in-state applicants over out-of-state applicants in contravention of the U.S. Constitution’s Commerce Clause.
That case, filed in federal court in the Northern District of New York late last year, disrupted license applications in much of the state until the Second Circuit Court of Appeals modified the injunction, and limited it to the one region where the out-of-state applicant may have qualified for licensure. Shortly thereafter, OCM settled with the out-of-state applicant, promising him first crack at a non-conditional license in the Finger Lakes region.
To show support for OCM, dozens of conditional use applicants and licensees gathered outside the Ulster County Courthouse on Friday, only to have their hopes dashed as the Court extended its temporary order for an additional two weeks.
All bets are on a settlement, as OCM gets ready to open applications to more groups this fall.
Military Vets Secure Temporary Restraining Order Against NYS — Blocking New Cannabis Licenses
August 8, 2023 – Four military veterans secured a temporary restraining order against New York State, blocking the Office of Cannabis Management from issuing new cannabis licenses.
The veterans claimed they were unable to secure retail licenses because the State illegally favored “justice involved” applicants over others. A similar suit was filed in March by Coalition for Access to Regulated & Safe Cannabis.
The veterans charged that cannabis regulators committed “unconstitutional overreach” when it created a system awarding licenses that gave priority to applicants with prior marijuana convictions and their immediate family members.
The restraining order was signed Monday by Supreme Court Justice Kevin Bryant, halting new licenses pending a hearing set for Friday morning in Kingston. The Cannabis Control Board is not meeting again until September. New licenses are generally issued at public meetings.
The order prohibits regulators from “processing” or “conferring operational approval” of pending licenses. It specifically blocks regulators from issuing new licenses and from allowing approved operators that have not yet opened their doors from opening dispensaries.
Justice Bryant ruled that the restraining order was necessary because “there is genuine urgency and that immediate and irreparable injury, loss, or damage will result” if the licensing program moves forward.
Although the 2021 licensing law defines, “social and economic equity applicants” as people from communities disproportionately impacted by cannabis enforcement, minority-owned businesses, women-owned businesses and service-disabled veterans, OCM has only addressed those impacted by cannabis enforcement — closing the door on other applicants similarly eligible to apply and receive licenses. In other words, the legislature did not specify that “justice involved” applicants should get priority over service-disabled veterans and women or minority owned businesses.
The petition filed in state Supreme Court in Albany last week accuses officials of changing the rules established by the Legislature that required “the initial adult-use cannabis retail dispensary license application period shall be opened for all applicants at the same time.”
The four veteran plaintiffs charged that the Office of Cannabis Management failed to follow New York’s Marijuana Regulation and Taxation Act (MRTA), in part by not issuing licenses to disabled service veterans and other minority groups.
463 conditional retail licenses were issued to applicants with prior cannabis convictions. A few non-profit agencies have also received approvals to open dispensaries.
“It’s out of character for a veteran to sue the state to uphold a law,” William Norgard, a U.S. Army veteran and one of the plaintiffs, said in a statement issued by a public relations firm announcing the lawsuit. “We take oaths to defend the laws of our nation, and trust — maybe naively — that government officials will faithfully and legally execute those laws. What the Office of Cannabis Management is doing right now is in complete breach of that trust. As veterans, we know that someone has to hold the line.”
The marijuana enabling legislations set a goal of awarding 50 percent of all retail marijuana retail licenses to social and economic equity applicants, which regulators read gave them the authority to give priority those with cannabis convictions or their family members.
The Office of Cannabis Management does not comment on pending litigation.
Guidance Issued For Cannabis Growers’ Showcases
August 1, 2023 – According to the CCB, a Cannabis Growers Showcase or CGS means a temporary event approved by the Office authorizing AUCC and AUCP licensees to showcase cannabis products which shall be sold by CAURD licensees to customers. The “guidance” was published on July 20, 2023.
A Conditional Adult-Use Retail Dispensary (CAURD) licensee or an Adult-Use Conditional Cultivator (AUCC) licensee may apply to be a Cannabis Grower Showcase Organizer (CGSO) for a Cannabis Grower Showcase or “CGS”, granting them authorization for temporary retail sales at an approved location.
The guidance is extremely detailed and complex, and seems to undermine the intent of the program — to provide outlets for unsold cannabis products, to connect growers and retailers, and to provide additional outlets for retaiil sales to blunt the prevalence of illegal sellers offering substandard product.
To be eligible, the CGSO must partner with at least three (3) or more cultivators and a licensed dispensary. The CGS Vendor will be authorized to sell cannabis products, produced, and distributed by the participating AUCCs, to customers. For every three (3) AUCCs participating, one (1) Adult-Use Conditional Processor (AUCP) may participate. For every three (3) AUCCs participants beyond the first three (3), an additional CAURD may participate as an additional CGS Vendor. At least one (1) of the participating AUCCs must be someone the CAURD does not currently carry in their storefront or delivery only inventory.
All participating CGS Vendors must be CAURD licensees with final retail authorizations, including those who have been approved to operate temporary delivery only locations and have received a license certificate from the Office of Cannabis Management and adult-use cannabis tax registration from the Department of Taxation and Finance. In other words, unless you are an approved licensee with an approved and operating retail location, you can’t participate.
And, all Cannabis Growers Showcase Organizers must submit a letter of approval signed by an official or representative from an administrative body responsible for event permitting in the city, town, or village where the CGS is to take place on official letterhead, that states the location, days, and times at which cannabis products are being offered for sale or sold. Cannabis Growers Showcases may only be held on premises in municipalities that have not opted-out of allowing cannabis retail dispensaries to operate within their jurisdiction pursuant to Section 131 of the Cannabis Law. A list of municipalities that have opt-ed out of retail dispensaries is available on the Office’s website: https://cannabis.ny.gov/local-government.
Authorized inventory for retail sale at a CGS include:
• cannabis products;
• cannabinoid hemp products (only if granted a Cannabinoid Hemp Temporary Retail Permit by the Office to sell hemp);
• cannabis paraphernalia;
• merchandise including stationary, gifts, and other minor incidentals;
• branded merchandise and apparel containing the licensee’s brand, including jewelry and accessories (in adult sizes only); and
• other items as approved by the OCM.
No samples of cannabis products are allowed to be offered at a CGS.
To view the complete guidance, click here...
Plans For Growers Showcase Events At Concerts, Fairs And Festivals Moves Forward
July 23, 2023 – New York’s Cannabis Control Board approved a measure last week that would allow, though only temporarily, the sale of cannabis products at “growers showcase” events.
The Cannabis Control Board approved the so-called “Cannabis Grower Showcase Initiative,” allowing farmers to partner with licensed retailers to sell pot at events, including farmer’s markets.
“Showcase” sales can occur at concerts, fairs and festivals, though no actual regulations governing this new sales vehicle have been proffered or developed. Experience with the Board dictates that regulations may still be a far-away occurrence, if past practices equal prologue.
The plan is intended to help New York growers who have had to warehouse the hundreds of thousands of pounds of marijuana cultivated last year with few places to sell legally. The state’s slow roll out of retail sales has put dire financial strain on many growers.
Early discussions indicate that each event would require the sale of product from at least three cultivators and one retail licensee to qualify. Sales would only be permitted in venues in municipalities that allow cannabis retailing, and within those municipalities, local zoning may limit the availability of venues. Also, the venues cannot be at places where “it can reasonably be expected that the primary audience is going to be underage,” state Director of Cannabis Policy John Kagia said.
For example, while a farmers’ market may be a “showcase” venue, it can only happen if the location of the farmers’ market was zoned for retail cannabis sales.
The state’s commitment to “showcase” sales is difficult to gauge, as the agency has flip-flopped on allowing the sales of product outside its licensed retail locations.
The Cannabis Association of New York issued a statement Wednesday cautiously commending the board for approving the measure. “This is an initiative we have supported with thoughtful and evidence-based recommendations to the Office of Cannabis Management,” CANY said in its statement.
“But now, as with any new program, the devil is in the details. We await the details of the ‘grower’s showcase’ and look to see how the OCM will put this into practice.”
212 New Conditional Adult Use Retail License Issued Statewide; 18 More In Mid-Hudson Region
The Cannabis Control Board voted Wednesday to approve 212 additional CAURD retail licenses.
Licenses were awarded to 46 applicants in Manhattan, 44 in Brooklyn, 28 in the Capital Region, 24 on Long Island, 18 in the Mid-Hudson region, 14 in Queens, nine each in the Finger Lakes, Western New York and the Bronx, five in Richmond, four in the Southern Tier and one each in Central New York and the Mohawk Valley.
The eighteen new licensees in the Mid-Hudson are:
It marks another, but unexpected, expansion of the state’s Conditional Adult-Use Retail Dispensary license program, which prioritizes applicants with a cannabis conviction under former drug laws or people who have a family member with a previous conviction.
“This expansion is necessary to help prepare New York’s market for the next phase of adult-use cannabis,” Office of Cannabis Management Executive Director Chris Alexander said at Wednesday’s meeting. “The decision to further expand the CAURD program will help ensure the retail market is robust enough to sell the cannabis grown by New York farmers and accelerate the transition of New York consumers from the illicit to the legal market.”
Licensees must still secure retail locations and submit plans for approval to OCM.
The board has awarded 463 conditional adult-use licenses to date, though the program, expanded several times since inception, was initially intended for 150 licenses.
“The provisional approval of today’s 212 CAURD licenses by the Cannabis Control Board marks a momentous leap forward in our pursuit of an inclusive and fair cannabis industry,” Cannabis Control Board chair Tremaine Wright said in a statement Wednesday. “These licensees are demonstrative of the innovation and diversity of New York state.”
Of the 463 licenses, only 20 legal dispensaries are open across New York.
The board will approve one more tranche of CAURD applications in the coming months, with additional applications opening outside the social equity program this fall.
For a complete list of new licensees, sorted by region, click here.
Two More Licensed Adult-Use Cannabis Retailers Open
June 19, 2023 – Marijuana Monday welcomes the Flynnstoned Cannabis Company, 219 Walton St Syracuse, NY 13202, (315) 299-9334; License Number: OCM-CAURD-23-000010
Hours: Sunday, 10:00am-8:00pm; Monday through Thursday, 10:000am-9:00pm, Friday-Saturday, 10:00am-10:00pm; Website:flynnstoned.com
Also, and a bit closer to home, welcome to Sesh, NYC, a delivery only location. No in-person sales are allowed at this location. According to its website, Sesh serves customers in the Bronx, lower Westchester, and upper Manhattan. License: OCM-AURC-TD-P23017; Website: myseshnyc.com
With the opening of these locations, there are now 15 licensed retailers across New York State. For a complete list, click here.
New York’s Cannabis Control Board Approved 34 Additional CAURD Licenses Thursday
Seven licenses were approved for the Finger Lakes region – the last region to receive approvals after litigation holding up the issuance of licenses there was resolved.
In addition to the seven Finger Lakes licenses, licenses were also awarded as follows: Bronx (2), Brooklyn (7), Central New York (2), Manhattan (2), Mid-Hudson (10) and Queens (4).
The provisional licensees are now able to submit final application materials to the state, enabling them to receive final licensure and open their retail dispensaries.
Currently there are 15 open cannabis retailers statewide and over 40 in development. Over 250 licenses have been approved across the state, with 21 percent of New Yorkers now living in a city with legal cannabis access.
OCM also reported that New York legal cannabis sales so far this year total $22.6 million.
At the meeting, growers continue to express frustration over the slow speed of the industry roll-out, saying the lack of sales outlets are causing financial hardship and endangering their continued participation.
Efforts to Close Down The Illicit Retail Market Gain Traction – Enforcement Outside NYC Started Last Week
The Office of Cannabis Management and the Department of Taxation and Finance began their first joint inspections authorized by new enforcement laws the week of June 5, 2023, in New York City, where inspections will remain active and ongoing. The two agencies inspected 11 shops in Manhattan last week.
All of the shops inspected in New York City last week were selling cannabis without a license and were issued Notices of Violation and Orders to Cease Unlicensed Activity.
The following shops were inspected last week:
- Varieties on Broadway – 736 Broadway
- Roll 2 Nation – 738 Broadway
- Baby Jeeter – 793 Broadway
- Maze – 16 St. Marks Place
- LaGuardia Smoke – 510 LaGuardia Place
- Nomad – 59 West 30th Street
- Play lane – 117B W 23rd Street
- Cannabis Culture – 403 8th Avenue
- Smoke Factory – 287 7th Avenue
- Go Green Dispensary – 603 6th Avenue
- Daydream – 1181 Broadway
“We continue to take action against bad actors who seek to skirt around our laws,” Governor Hochul said. “Unlicensed dispensaries violate our laws, put public health at risk, and undermine the legal cannabis market, and we will continue to take these critical enforcement measures to protect New Yorkers from illicit, unregulated sales.”
On May 3, 2023, Governor Hochul signed legislation enabling for the enhanced, statewide enforcement by OCM on unlicensed cannabis businesses. The legislation now enables OCM to also assess civil penalties against unlicensed cannabis businesses, with fines of up to $20,000 a day for the most egregious conduct, and starts the process of potential closure of a retail location selling cannabis without a license among other penalties.
The new law also makes it a state crime to sell cannabis and cannabis products without a license.
Inspections also took place at storefront businesses not licensed to sell cannabis in Ithaca and Binghamton.
The following shops were inspected in Ithaca:
- Black Leaf — 103 East State Street, Ithaca, NY
- Zaza Convenience — 101 East State Street, Ithaca, NY
- The Rezz — 312 Fourth St, Ithaca, NY
The following shops were inspected in Binghamton:
- Green Magic – 144 Henry St
- Takeoff 2 – 63 Chenango St
Governor Hochul Unveils New Statewide Cannabis Public Education Campaign
“Why Buy Legal New York” Will Encourage New Yorkers to Purchase Safer, Regulated Cannabis Products from Licensed Dispensaries
April 22, 2023 – Governor Kathy Hochul announced the launch of “Why Buy Legal New York”, a public education campaign promoting safer, informed, legal purchases of cannabis from licensed dispensaries in New York State.
The campaign focuses on three key pillars: protecting public health and promoting social equity and community reinvestment. Governor Hochul made the announcement alongside the New York State Office of Cannabis Management at CUNY Law School in New York City. The “Why Buy Legal New York” announcements explain and emphasize the potential health risks associated with purchasing cannabis products from unlicensed businesses and why regulated cannabis products are safer. It also outlines how buying legal supports the advancement of New York’s social and economic equity goals for communities across the State.
“To bolster the public health and safety of all New Yorkers, we are providing them with information they need to make informed decisions and enjoy cannabis responsibly,” Governor Hochul said. “As we continue to build a healthier and more equitable cannabis market, I am proud to launch this important public education campaign to promote safer, legal purchases of cannabis from licensed dispensaries throughout our state.”
The primarily digital campaign will target cannabis consumers 21 years old and over and includes various educational materials, such as “The Guide to Safer Cannabis Consumption”. These materials will provide information on how to find legal dispensaries in New York and tips on how to consume cannabis safely. Materials are available at: https://cannabis.ny.gov/consumers.
Section 280E Tax Relief Available To Cannabis Businesses In New York State; Federal Relief Proposed
April 18, 2023 – Earl Blumenauer, a Congressman from Oregon, introduced a bill this week that would allow legal marijuana businesses to take tax deductions they have been historically denied, despite their availability to other legal businesses.
The Small Business Tax Equity Act (H.R. 2643), would allow marijuana businesses operating in compliance with state laws to take business deductions associated with the sale of marijuana. Section 280E of the federal tax code currently prevents cannabis businesses from deducting ordinary expenses associated with running a small business, including rent, utilities, and payroll.
Legally operating marijuana businesses cannot claim the Work Opportunity Tax Credit when they hire veterans, cannot depreciate American-made irrigation equipment, and cannot take any credit or deduction relating to construction or operation costs to revitalize or restore a building.
“State-legal cannabis businesses are denied equal treatment under 280E. They cannot fully deduct the cost of doing business, which means they pay two or three times as much as a similar non-cannabis business,” said Blumenauer, founder and co-chair of the Congressional Cannabis Caucus. “This grotesquely unfair treatment incentivizes people to cut corners. If Congress wants to get serious about supporting small businesses and ending the illicit cannabis market, it is commonsense that we allow legal cannabis operations to deduct business expenses, just like any other industry.”
Even if passage of federal legislation is an uphill climb, New York State has taken steps to decouple state taxation from federal returns.
A law contained in New York State’s Budget carved out an exemption from IRC Section 280E. This exemption allows NYS-licensed cannabis businesses to take tax deductions for business expenses and claim credits at the state level that they are barred from utilizing on their federal returns.
By decoupling the state tax code from the federal law for purposes of 280E, New York-licensed cannabis businesses would see significant tax savings beginning in tax year 2023.
Many states simply mirror federal tax policy in their own tax codes. Because of this, the federal tax code’s restrictions on cannabis businesses also blocks state-level deductions unless a state acts to exempt these businesses from these restrictions.
Because of the connection to federal returns, it is estimated that many cannabis businesses pay effective tax rates of up to 80%. To help resolve the issue, New York has joined California, Colorado, Oregon, Massachusetts, and other states to provide relief. Nineteen states have decoupled state returns from federal returns.
A bill pending in Connecticut would similarly decouple state and federal tax returns. When neighboring states have different tax structures, competition suffers.
Forcing a business operation to pay taxes on gross revenue, where it cannot deduct payroll, rent, utilities and other expenses is a recipe for near-certain economic failure, and encourages the continued proliferation of the illicit marijuana trade.
A Tangle of Lawsuits Is Crippling New York’s Entry Into Legalized Cannabis Sales
March 29, 2023 – Let’s face it. New York’s legalization and launch of licensed cannabis retailers has been less than perfect. Okay, it’s been a disaster. To date, there are only a handful (less than five) retail cannabis operations open, and those are only open conditionally.
Illicit sellers and retailers abound, offering marginal product, paying no taxes, and unafraid of State or local law enforcement.
The preference given to those with prior involvement with cannabis-related offenses has closed the market to the thousands of other operators vying to open up shop. The system of in-state preferences has basically shut down the industry in the Hudson Valley and other areas of the state, while a federal lawsuit grinds its way through courts that are part of a system that still holds cannabis to be illegal.
What’s to be done to jump-start the industry, or to keep it from collapsing under its own regulatory weight?
A group of New York-affiliated medical cannabis operators filed a complaint against the state’s regulators asking the Court to open available licensing options to all retail dispensary applicants – not just those with prior marijuana convictions. The Coalition for Access to Regulated & Safe Cannabis (which includes Acreage Holdings, PharmaCann, Green Thumb Industries, and Curaleaf, and several hopeful dispensary owners) filed suit against New York’s Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB), the two agencies charged with devising and implementing the state’s cannabis legislation.
The lawsuit filed in Albany County Supreme Court on March 16 alleges: (1) unconstitutional overreach and policymaking; (2) the abdication of the agencies’ duties, and (3) negligent actions that needlessly put New Yorkers’ health and safety at risk.
Plaintiffs allege that defendants failed to fulfill the requirements of the Marijuana Regulation and Taxation Act (MRTA), the law that legalized cannabis in New York in March 2021. It’s main argument though is that defendants failed to follow the law itself and provide all applicants with equal access to retail dispensary licenses. They say the entire Conditional Adult-Use Retail Dispensary (CAURD), which restricts eligibility to those with prior involvement in cannabis-related offenses, runs afoul of the law, and has no basis in statutes that established legalized cannabis.
They argue that the agency had no right to limit access to dispensary licenses to a specific group of individuals, as opposed to providing equal access to all to available licenses.
The list of failures continues: a delay of 20 months in proposing regulations for the marketplace, still unfinished; constant changing guidance for growers and processors; failures to realize promised state-subsidized real estate and loans; allowing the cultivation of large quantities of cannabis before establishing a retail infrastructure to sell it; and countless other incidents of mismanagement and incompetence.
The complaint narrative blames the defendants through inaction of allowing the illicit market to thrive, not stopping tainted cannabis products from entering the illegal market, and depriving communities of essential tax revenue.
The narrative also refers to a report (detailed earlier in this newsletter) commissioned by the New York Medical Cannabis Industry Association (NYMCIA) and others that highlighted that about 40% of marijuana products sold in New York’s unlicensed businesses contain potentially harmful contaminants. And it blames the state for failing to shut down unlicensed operators while pointing out the folly of sending “cease and desist letters” to illegal sellers and the failures of law enforcement operations to impact the illegal markets. Estimates are that over 1,400 unlicensed businesses are operating throughout the state, resulting in the likely loss of around $2.6 billion in tax revenue over the next seven years.
Plaintiffs (in a blend of an Article 78 and request for declaratory relief) have asked the court to declare OCM’s CAURD license unconstitutional and outside the agency’s legal authority. It asks the Court to require regulators to take legal action against all illegal cannabis stores. And most important to their interests: to open the licensing process for adult-use retail dispensaries to all applicants now, including registered organizations and those who qualify under the MRTA’s social and economic equity provisions.
Second Circuit Court of Appeals Modifies Injunction, Clearing The Path To Issuance of Dispensary Licenses in Hudson Valley
Finger Lakes Remains Under Injunction; Only A Handful of Rockland County’s Villages Opted In For Retail Licenses
March 29, 2023 – In a one-paragraph Order, issued late Tuesday afternoon, the Second Circuit Court of Appeals cleared the path for the New York State Office of Cannabis Management (OCM) to issue retail cannabis dispensary licenses in the Hudson Valley, Brooklyn, Central and Western New York. The Circuit Court left in place a ban on the issuance of licenses in the Finger Lakes but set an expedited briefing schedule to address issues affecting that region.
The ban arose last November, when a District Court Judge in the Northern District of New York entered a sweeping order halting OCM’s ability to issue retail licenses in the Hudson Valley and other areas. An out-of-state applicant for dispensary licenses claimed his company was discriminated against based on a system of preferences favoring in-state applicants.
The plaintiff, Variscite NY One, Inc. of Michigan, convinced Judge Gary Sharpe that the system New York used to award licenses violated the Commerce Clause of the US Constitution. The Commerce Clause generally prohibits a state from favoring its own residents over out-of-state applicants in commercial matters.
Judge Sharpe halted the issuance of licenses in every region where Variscite sought one, including the Hudson Valley.
OCM’s efforts to lift the injunction or at least modify it at the District Court level went nowhere. OCM was also denied a stay from the District Court pending appeal.
In seeking to modify the injunction, or limit its application in the District Court, OCM argued that no applicant could have obtained a retail dispensary license in more than one area of the state because the number of applicants in each area precluded any applicant from securing a second regional license. It also argued that even if Variscite had received full credit for in-state residency, it would not have otherwise scored high enough to secure a retail dispensary license.
OCM appealed to the Second Circuit and sought again to have the injunction lifted or modified. Its arguments resulted in a partial victory yesterday, clearing the path for issuance of licenses in every area except for the Finger Lakes – Variscite’s first preference for licensure.
The Second Circuit entered an order late Tuesday afternoon saying, “The district court’s injunction is modified so that it bars the issuance of conditional adult-use retail cannabis dispensary licenses only in the Finger Lakes region.”
The NYS Office of Cannabis Management tweeted that, “We are excited to begin advancing licenses to these regions shortly.”
“New York’s brand-new cannabis industry is making significant progress to promote social equity and right the wrongs of the past, creating the fairest and safest market in the nation,” New York Gov. Kathy Hochul said in a prepared statement. “This decision will allow New York’s social equity entrepreneurs to open safe, regulated cannabis dispensaries in Central New York, Western New York, the Mid-Hudson Region and Brooklyn. For the first time, New Yorkers in nearly every region of the state will have access to safer, high-quality, adult-use cannabis products. I am committed to ensuring New York continues to lead the nation in our safe and equitable approach to the cannabis market.”
The temporary injunction against OCM prevented the issuance of 18 licenses, six of which would have allowed retailers to operate in the Mid-Hudson Region. The identities of the six Mid-Hudson retailers are being withheld pending a formal announcement.
Earlier this month, OCM announced its intent to issue an additional 150 retail dispensary licenses on top of the 150 previously authorized.
According to a database compiled by Office of Cannabis Management, in Rockland County, only the Villages of Haverstraw, Nyack, Piermont, Chestnut Ridge and Airmont have opted-in to allowing retail dispensaries in their municipal borders. These villages have opted-out of allowing on-site consumption lounges.
Hudson Valley Retail Dispensary Licenses Could Issue Soon If Second Circuit Court of Appeals Lifts Injunction
Argument is set for March 28th at the Second Circuit Court of Appeals in Manhattan
March 20, 2023 – The Second Circuit Court of Appeals is being asked to stay the preliminary injunction issued by United States District Court (Northern District of New York). The injunction issued below barred the New York Office of Cannabis Management (OCM) from issuing any conditional adult-use retail dispensary (CAURD) licenses in the Finger Lakes, Central New York, Western New York, Mid-Hudson and Brooklyn regions during the pendency of the lawsuit.
The injunction is why there are no retail dispensaries opened or licensed in the Hudson Valley. The plaintiff below (Variscite NY One, Inc.) convinced Judge Gary Sharpe that he was being discriminated against as an out-of-state applicant and that OCM was favoring in-state applicants in contravention of the Commerce Clause of the US Constitution. The Commerce Clause generally prohibits a state from favoring its own residents over out-of-state applicants in commercial matters.
OCM’s efforts to lift the injunction or at least modify it at the District Court level went nowhere. OCM was also denied a stay from the District Court pending appeal. Now, in the appellate case in the Second Circuit Court of Appeals, OCM is trying again to get a stay, or a modification of the injunction that would allow it to finally issue licenses in the affected areas.
In its motion for a stay, OCM argues that Variscite met the “significant presence” licensing requirement because it is incorporated in New York; therefore, the cannabis company is not being discriminated against. OCM also argues (as it did at the District Court) that Variscite’s application did not otherwise score high enough to qualify for a license, essentially saying that he could not have secured a license even if he was given full in-state credit because of other factors in his application.
OCM also argued:
The residency requirements do not violate the Dormant Commerce Clause because they do not discriminate against out-of-state actors, and if the requirements do “burden” interstate commerce, that does not exceed the state’s interest to rectify the harm caused by its historical marijuana laws and the selective enforcement of those laws.
The state will suffer irreparable harm if the injunction is not lifted. “The preliminary injunction leaves the putative recipients of 54 dispensary licenses indefinitely unable to do business and threatens the economic stability of cannabis growers and manufacturers who will, as a result of the injunction, lack enough buyers for their goods.”
Variscite argued against lifting stay blocking New York from issuing the licenses, saying the state is aiming for a “backdoor dissolution” of the injunction that would leave him without the possibility of a remedy.
When New York legalized marijuana, it established residency requirements to curtail outside entities from entering and dominating a newly legalized state market from afar. Meanwhile, the law is very unsettled on residency requirements with many experts believing that until marijuana is legalized nationally, the Commerce Clause does not apply and cannot be violated because there is no legal interstate commerce of cannabis – a drug illegal under federal law.
Courts don’t regulate illegal markets.
With a trial date in the District Court set for mid-2024, the uncertainty surrounding New York’s cannabis market continues, further delaying the approval of 54 licenses in the five territories under injunction.
Let’s just say that the regulatory landscape for the cannabis industry is still very much unsettled.
Women in New York Are Being Left Behind In Retail Dispensary Licensing
March 13, 2023 – In two rounds of license awards, women won only seven percent of Conditional Adult-Use Retail Dispensary (CAURD) licenses in the first round and 14 percent in the second round.
New York’s social equity program was designed to grant CAURD licenses to qualified entrepreneurs who have either been convicted on a marijuana charge or who had an immediate family member similarly situated. The program was designed to mitigate decades of disproportionate drug enforcement, particularly in communities of color.
To further make up for past harms, New York is also committing to startup funding and real estate assistance to licensees.
So, why have women not fared well in the issuance of licenses? Is it because marijuana enforcement laws were disproportionately aimed at young men of color? Statistics tell part of the story.
Between 1997 and 2007, 91 percent of people arrested for marijuana possession in New York City were male, according to a report from the ACLU of New York. Of that male cohort, young Black and Latino men were overwhelmingly the prevalent demographic in marijuana possession arrests during that time period.
To open the door to more women, New York crafted its regulations to include immediate family members of convicted individuals in the qualifying pool of applicants.
“My team early on made an effort to make sure that women have a pathway to get a CAURD license,” said Damian Fagon, chief equity officer of the Office of Cannabis Management.
Despite that effort, a review of the scoring, qualifying based on a conviction is weighted higher than one based on a family member, effectively building in a bias toward men.
There have been calls for both more transparency and reconsideration in the application process — particularly when it comes to awarding points for the “justice-involved questions” on the license application.
The OCM does not make applications, the information contained therein, or its scoring results public when it comes to license awards, as public disclosure may advantage certain applicants who might shape their applications toward those categories weighted more heavily. Secrecy in the awarding of licenses is OCM’s way.
The built-in bias against women remains the norm, and no efforts are underway to re-tilt the tables. Preferences for distressed farmers and disabled veterans will also likely favor men as demographically men dominate those categories as well.
The expansion from 150 to 300 licenses recently did improve the raw numbers for women, but women still remain grossly under-represented in the retail dispensary market.
New York Expands Conditional Licenses to 300
Applicants with a family history of marijuana convictions will soon be eligible to open dispensaries with conditional licenses.
March 6, 2023 – Cannabis regulators will issue 300 retail shop licenses to applicants impacted by past marijuana convictions, expanding the original cohort from just 150 in the first round.
“As we’ve continued to review applications we found there’s still many qualified individuals who can make the most of this opportunity outside of that initial 150,” Chris Alexander, executive director of the Office of Cannabis Management, said at the most recent meeting of the Cannabis Control Board.
There were originally about 900 applicants for conditional licenses, with 150 granted.
Plans to provide the first 150 licensees with access to turnkey locations and loans from a state-initiated fund remain unchanged. Should any from the original 150 licensees decline the resources offered by the State, new applicants may become eligible for those same benefits.
The actual increase in license opportunities will be in line with the original geographic awards, largely based on populations within the different established regions.
Nothing in the issuance of new license opportunities affects the Hudson Valley. A federal court ruling from the Northern District of New York has kept licensing of shops on hold in five of New York’s 14 regions: the Finger Lakes, central New York, western New York, Mid-Hudson and Brooklyn. The federal court injunction arose from an out-of-state challenge of the New York’s policy prioritizing the awarding of licenses to in-state residents.
Efforts to modify or lift the injunction fell on deaf ears in the District Court. The decision is under appeal, but the process will leave these new potential licensees in the same limbo as the original cohort in the affected regions.
What To Do With All That Weed?
February 27, 2023 – In its first harvest, in what some would call an “upstate cultivation boom” 300,000 pounds of weed were produced, valued at three-quarters of a billion dollars.
Here’s just one example, Hudson Cannabis reports it has 2,700lb of harvest bud stacked in storage containers waiting to be certified by one of the five state-approved testing labs. At an approximate wholesale market value of $300 a pound, her inventory is valued at $800,000. That’s today’s value. By most estimates wholesale prices are likely to decrease based on oversupply. Hudson Cannabis is licensed to produce 43,000 sq ft of cannabis flower, 29,000 sq ft of which are grown outside.
And, there are only a handful of state-licensed dispensaries with open doors and delivery services are nascent. So, what’s going to become of all of that product. Lines at open dispensaries snake around the blocks where they are located – some with “bouncers” to moderate the crowd. How many new retailers are ready to open?
So where will all of that product go? What about all of that tax revenue that the state touted?
As of March 2022, weed-legal states reported a combined total of $11.2bn in tax revenue from legal, adult-use cannabis sales. By some estimates, the legal cannabis market could reach $66bn by 2025. What’s up New York?
What can be done to get the dispensaries open a bit faster?What about roadside “pick-your-own” at some farms to help out the cultivators and farmers that invested with the hope that a legal framework would provide them a return on their investments? And, how much product will have to be processed for its active ingredient or sold to edible-product producers, given the dearth of dispensary and delivery options? How much will end up untested and on the black market?
New York’s Office Of Cannabis Management Asks District Court To Modify Its Injunction And Allow Retail Cannabis Sales In Hudson Valley
December 27, 2022 – An injunction entered against New York’s Office of Cannabis Management (OCM) last month is preventing the issuance of any retail cannabis dispensary licenses in the Hudson Valley and four other regions in New York State. But a court filing by the OCM last week may clear the way for approved licensees in the Mid-Hudson region and three other blocked areas to open retail dispensaries.
The case was originally filed by Variscite NY One, Inc., through Michigan-based Kenneth Gay, its 51 percent owner, who claimed that application requirements for retail dispensary licenses in New York violated the Commerce Clause of the U.S. Constitution because the law favored New York residents over out-of-state applicants. The Commerce Clause generally prevents a state from favoring its own residents over out-of-staters in commercial matters.
Variscite had filed an application listing five areas where it sought a retail license, including its first preference, the Finger Lakes, as well as Central New York, Western New York, the Mid-Hudson Region, and Brooklyn. New York is divided into fourteen different geographic zones for retail licensing. Based on the information available to the Court at the time, it agreed with Variscite and issued an order granting Variscite temporary relief, which has prevented OCM from issuing licenses in the five regions.
OCM in its recent filing is attempting to show the court that only licenses in the Finger Lakes region should be at issue, while the other regions shouldn’t be affected because of the way the New York law is written. The law says an applicant can only get its first choice of region when there are an insufficient number of applications for its second and later choices. At best, Variscite would only be eligible for a license in the Finger Lakes region, according to the filing.
In its request to modify the injunction, OCM stated that approved retailers, processors and cultivators in the Hudson Valley (and the other affected regions) would be irreparably harmed if the Court did not narrow the injunction to the one area where the Petitioner may have be eligible for a retail dispensary license.
OCM also states in its affidavit that Variscite would not have even qualified for a license in the Finger Lakes region because it did not score high enough on the qualifying application to have been selected.
OCM also told the Court that the injunction affects the economics of “54 potential retail dispensaries, 121 licensed cultivators, and 16 processors,” many of whom have invested millions of dollars in their operations relying on OCM’s licensing regulations. What the defendant is saying is that if the retailers can’t get up and running, then the entire eco-system of the cannabis market will be disrupted.
The OCM received more than 900 applications for Conditional Adult Use Retail Dispensary (CAURD) licenses. The Board recently approved 36 provisional licensees, including 28 qualifying individuals, and eight nonprofit CAURD applicants outside the five areas included in the lawsuit. The temporary injunction against OCM prevented the issuance of an additional 18 licenses, six of which would have allowed retailers to operate in the Mid-Hudson Region. The identities of the six Mid-Hudson retailers are being withheld pending the outcome of the litigation.
Per the law, up to 175 licenses will be granted; roughly 150 may be granted to individual applicants, and about 25 to nonprofit applicants. It it expected that there will be 17 Mid-Hudson licenses approved.
In addition to asking to modify the injunction, OCM has also filed an appeal, a request to the court to delay enforcement of its order, and a motion to dismiss Variscite’s complaint.
Variscite filed a similar case in California, also claiming a violation of the Commerce Clause, but earlier this month the District Court in California dismissed the complaint, finding Variscite lacked standing to pursue its case. The court in denying Variscite’s claims also questioned if the Commerce Clause even “applies to federally illegal cannabis markets.”
It remains uncertain as to whether Commerce Clause violations are applicable to markets and products that are still illegal under federal law. Marijuana is a Schedule I substance under the Controlled Substances Act.
The case number in New York’s Northern District is: 1:22-cv-01013-GLS-DJS.
How Do You Know If Your Cannabis Retailer Is Legitimate (Licensed)?
December 16, 2022 – We recently reported on the dangers of purchasing adulterated cannabis from unlicensed retailers in New York City. But, how does a consumer know if their retail outlet is actually licensed by New York State? State officials are taking steps to steer consumers to licensed retailers. With the first round of retailers ready to open their doors, the OCM unveiled a state-sanctioned icon and scannable QR Code that will be posted in the window of every licensed storefront in the state. Purchasers who buy from unlicensed retailers deprive the state of tax money and may take their health into their own hands.
“It is critical that consumers know and trust that the new, legal cannabis market offers tested products and follows protocols designed to protect public health,” said Tremaine Wright, chair of the Cannabis Control Board.
The state is also planning a marketing program called “Why Buy Legal New York” that’s set to launch in 2023. Other efforts to crack down on illegal sales are also in the works to shut down illegal storefronts and trucks selling illicit and often tainted marijuana and cannabis products.
Home Delivery? Really?
December 9, 2022 – In an effort to assist a fledgling cannabis market and enable retailers who have yet to open their doors distribute their products, the Office of Cannabis Management has issued delivery guidelines that allow for home delivery of cannabis products. The new regulations will allow:
- Retail licenses to secure a warehouse from which to fulfill delivery orders while building permanent dispensary locations for up to one year;
- Customers to place online and phone only; no in-person sales or pick-up from the warehouse location;
- Customers must pre-pay; no cash payments from cannabis consumer to delivery employee permitted;
- Deliveries can be made by bicycles, scooters, motor vehicles;
- Consumers must be at least 21-years-old with valid identification upon sale and delivery;
- Businesses can have up to 25 delivery staff per business, as dictated by New York state cannabis law.
One reason for the rush to home delivery is likely the enormous backlog of warehoused product from the first growing and processing season. Hundreds of millions of dollars worth of cannabis grown in the state remains warehoused, for want of sales outlets. A report by Bloomberg estimates the value of the 300,000 pounds of warehoused cannabis to be in excess of $750 million dollars.
OCM Asks District Court Judge To Modify Injunction And Allow Sales In Enjoined Areas, Including Hudson Valley
December 12, 2022 – In a recent court filing in the Northern District of New York, the OCM has asked the Court to modify its injunction against issuing adult retail dispensary licenses in Central New York, Western New York, the Mid-Hudson Region and Brooklyn. In support of its motion, OCM relies on the fact that a petitioner/licensee, Variscite NY One, Inc., could have only received a license in its “first” choice area because there were more than the requisite number of applicants in the other areas. Under the rules established by the OCM, licenses would only be issued in 2nd or later choices if there was an inadequate number of applicants in the other areas.
As it relates to the Mid-Hudson region, OCM reports that it received 75 applications for 17 available licenses, and that approved retailers, processors and cultivators in the Hudson Valley (and the other affected regions) may be irreparably harmed if the Court does not narrow the injunction to the one area where the Petitioner may have be eligible for a retail dispensary license. Petitioner’s first choice for location was the Finger Lakes region.
OCM reports that the injunction affects the economics of 54 potential retail dispensaries, 121 licensed cultivators, and 16 processors, many of whom have invested millions of dollars in their operations relying on OCM’s licensing regulations. OCM adds in its affidavit that the applicant that sought and received the injunction would not have qualified for a license in the Finger Lakes region anyway, as it simply did not score high enough on the qualifying application to have been selected.
The case number in the Northern District is: 1:22-cv-01013-GLS-DJS.
A Hard Look At New York City’s Illicit Cannabis Dispensaries
November 29, 2022 – A report prepared by the New York Medical Cannabis Industry Association, the New Jersey Cannabis Trade Association, and the Connecticut Medical Cannabis Council reveals significant problems in New York City’s unlicensed and unregulated cannabis retail market. The report says that many of these locations falsely advertise the sale of THC products as legal or licensed, misleading consumers and selling products blatantly masquerading as popular name-brand chocolates, candies, gummies, and other well-known snacks.
In addition to deceptive advertising practices, these illicit operations and their products represent a significant public health concern. From 2019-2020, more than 2,000 individuals were hospitalized, and 60 people died due to illness caused by vaping-associated lung injury (EVALI), a phenomenon that was largely linked back to additives in illicit THC vapes like those currently sold in these illegally operating shops.
Testing of the products sold reveals an existing major health crisis. Results revealed the presence of several harmful contaminants, such as E. coli, pesticides, heavy metals, and salmonella in 40 percent of the illegal products purchased, including vapes. Many of the products tested did not contain the amount of THC advertised on the label and in one case, featured double the amount of listed THC. After reviewing the items under the state’s proposed branding regulations, 100 percent of the products failed.
And, tests conducted at independent labs found the presence of E.coli, salmonella, and pesticides in various products offered for sale. E.coli and salmonella were found in flower and edible products purchased at some locations. E. coli in cannabis can cause many types of infection and is most often associated with diarrheal illness and lung infections that can become dangerous. Also, if inhaled, salmonella bacteria can cause severe fevers and fatigue symptoms that can remit and relapse. Salmonella infection can also be extremely difficult to treat and can have prolonged detrimental effects.
Several products also contained heavy metals, including nickel and lead. Ingesting these contaminants in cannabis is also a cause for concern. Certain metals have the potential to cause headaches, nausea, and in cases of prolonged exposure, cancer, and organ failure. Respiratory illness can also occur upon combustion and inhalation of contaminated flower. To read the report, click here.
Proposed Regulations Affect Cultivators, Establish License Types and Tiers
The Office of Cannabis Management (OCM) has proposed changes to its adult-use cannabis program, with some changes specifically affecting cultivators.
The proposed regulations and licenses support a structure similar to New York’s alcohol industry, separating supply (cultivation, processing, distribution) from retail. The regulations maintain prohibitions on individuals having an interest in businesses across tiers. Essentially, operators or investors in a business on the supply side cannot also hold any interest in a retail business. This separation opens the market to more potential players and prevents the likelihood of concentrating economic power in a few stakeholders.
As the regulations affect cultivators, they create different tiers of cultivation licenses that are differentiated by light source. The allotted square footage per license ranges from 5,000 – 100,000 square feet. They also incentivize sustainable cultivation practices and limited energy utilization including outdoor cultivation.
Cultivators are divided into categories based on the size of the cultivation canopy and the type of cultivation: (1) outdoor; (2) mixed light; (3) combination of outdoor and mixed light; and, (4) indoor. Within each category, there are five different tiers based on “canopy” size ranging from less than 5000 square feet up to 100,000 square feet.
Under the regulations, “canopy” or “cultivation canopy” is an area measured in square feet using clearly identifiable boundaries of all areas(s) that will contain non-immature cannabis, vegetative or flowering, excluding seedlings or small clones. Under the regulations, canopy areas may be non-contiguous.
The regulations are not final until after a 60-day public comment period.
Cannabis Control Board Approves First Conditional Adult Retail Dispensaries, But No Licenses Issued In Rockland or Hudson Valley
NYS Cannabis Control Board Approves 28 Licenses for Business Owners with a Cannabis Conviction or a Family Member with a Cannabis Conviction, 8 Approved for Nonprofit Organizations.
November 25, 2022 – The Office of Cannabis Management received over 900 applications for CAURD licenses. At today’s meeting, the Board approved 36 provisional licensees, including 28 qualifying individuals and 8 nonprofit CAURD applicants. At least one CAURD license was granted in each available region of the state.
Because a federal judge temporarily blocked New York State cannabis regulators from issuing licenses in certain regions of New York, including the Hudson Valley, no conditional licenses were issued pending the outcome of that litigation. Regulators said that 18 additional successful applicants would have been announced in the first wave if a recent injunction by a federal judge hadn’t blocked them from issuing licenses in the Finger Lakes, central New York, western New York, Mid-Hudson and Brooklyn. Six of those licenses on hold are from the Mid-Hudson Region.
Going forward, up to 175 licenses will be granted in total: as many as 150 to individual applicants and up to 25 to nonprofit applicants and licenses applications will be sent to the Board for its consideration on a rolling basis.
Additionally, the Cannabis Control Board approved an additional 16 Adult-use Cannabis Conditional Cultivator Licenses, growing the total number of approved Adult-Use Cannabis Conditional Cultivator Licenses to 277. The approval of 8 Adult-Use Cannabis Conditional Processor Licenses raises the total issued by the Board to 33, and the approval of three laboratory permits brings the total to seven.
Judge Blocks Licenses for Some Cannabis Dispensaries in New York
November 10, 2022 – A federal judge temporarily blocked New York state cannabis regulators from issuing retail licenses amid a lawsuit by an applicant denied approval to operate in the state.
U.S. District Court Judge Gary Sharpe issued the injunction based on a legal challenge brought by a Michigan-based operator. Variscite challenged those provisions in the law that require that licenses for retail cannabis dispensaries be awarded to people who have been affected by New York state drug laws.
Variscite’s owner was previously convicted of a marijuana-related offense in Michigan. The affected regions — the Finger Lakes, Central New York, western New York, the Mid-Hudson region and Brooklyn — are areas in which Variscite had sought and been denied a license to operate.
Read the 29-page injunction here. The basis of the injunction was that the limitation to in-state licensees violates the federal interstate commerce clause, which generally prevents states from preferring its own residents over the residents of other states without a showing that its regulations or law are narrowly tailored to accomplish a legitimate purpose and that the preference to residents of its own state was in fact a legitimate purpose that could not be accomplished by other means.
“We don’t comment on pending litigation. The Office of Cannabis Management is committed to the Marijuana Regulation and Taxation Act’s goals of including those impacted by the state’s enforcement of cannabis prohibition in the market that we are building and we are additionally committed to getting New York’s cannabis supply chain fully operational,” said Office of Cannabis Management spokesman Freeman Klopott. “The Cannabis Control Board will soon have before it applications for the Conditional Adult Use Retail Dispensary license which will start closing that supply chain.”
Will President Biden’s Pardons Lead To De-Scheduling Marijuana And Passage Of The SAFE Banking Act
October 20, 2022 – On October 6, President Biden announced that he would issue pardons for all prior federal convictions for simple possession of marijuana, and urged state governors to do the same. President Biden also directed the Secretary of Health and Human Services (HHS) and the Attorney General to “initiate the administrative process to review expeditiously how marijuana is scheduled under federal law. ” Marijuana is classified as a Schedule I drug, along with heroin and LSD.
Questions abound as to the possibility that the executive action will usher in cannabis banking reforms. Should cannabis actually be de-scheduled, banks and financial institutions will be more willing banking with cannabis companies. And, there is wide-spread belief that Biden’s announcement may move Congress to finally pass the SAFE Banking Act, or some version of it.
The SAFE Banking Act – which has passed the House of Representatives seven times in recent years but has never been taken up in the Senate – would enable cannabis businesses to access the federal banking system and also allow providers to the cannabis industry such as attorneys, accountants, lenders and landlords to contract with and accept payment from cannabis businesses without the risk of violating federal law.
Applications for NY’s First Retail Marijuana Locations Are In
October 6, 2022 – With the first round of applications for New York’s Conditional Adult-Use Retail Dispensary licenses closed, some 900 hopeful entrepreneurs are now awaiting action on their applications.
New York’s Office of Cannabis Management has yet to publish regulations for any of the state’s nine general adult-use cannabis license categories. However, according to Syracuse.com, the state will issue up to 150 CAURD licenses, and recipients will open New York’s first legal adult-use dispensaries pursuant to those licenses.
Individuals who qualify for a CAURD license must have been arrested in New York for a cannabis offense (or have a family member who was) before March 31, 2021, and have run a profitable business for at least two years. License recipients will have access to storefronts that are currently being secured and will be built out into dispensary spaces by the Dormitory Authority of the State of New York (DASNY).
Plans also include granting 25 licenses to qualifying nonprofits, but those nonprofits won’t have access to the DASNY properties or New York’s $200 million social equity cannabis investment fund.
New York Set to Hobble ‘Legal’ Cannabis with Taxes and Regulations
September 6, 2022 – “Since June 1, the New York’s Cannabis Control Board has issued 162 recreational cultivation licenses,” Bloomberg Tax recently noted. “Those fortunate enough to obtain one of New York’s recreational cannabis licenses will be forced to contend with a gauntlet of state and local taxes.”
The analysis, prepared by three accountants, detailed a long list of sales taxes, corporate taxes, and “recently enacted adult-use cannabis taxes.” Given the number of jurisdictions involved and uncertainty as to how they’ll apply to businesses that won’t be able to open their doors until the end of the year, at soonest, the authors declined to guess at the final tax burden. But it will be high, and compliance a guessing game with penalties awaiting those who cross the authorities. It’s a good bet that many entrepreneurs accustomed to operating in the illicit market will remain underground rather than risk the costs and hassles of legal operation as envisioned by Empire State officials. After all, technical legalization hobbled by stiff taxes and regulation has already stumbled elsewhere. Read more…
An Update on New York’s Recreational Cannabis Market
As of June 1, New York state’s Cannabis Control Board has issued 162 recreational cultivation licenses. The first recreational retail licenses aren’t expected to appear until the end of 2022. According to Chris Alexander, executive director of the state’s Office of Cannabis Management, final regulations are still being designed. And while some dispensaries will probably be licensed by end of 2022, a mature market isn’t expected for another two to three years.
Also, by signing the 2022-2023 state budget into law, New York Gov. Kathy Hochul enacted Senate Bill S8009, freeing state cannabis taxpayers from the burdensome impact of IRS Code Section 280E, beginning January 1, 2023.
Section 280E disallows deductions and credits on federal returns for expenditures connected with the illegal sale of drugs, requiring retail cannabis businesses to add back such significant expenses as rent and wages for sales staff. Like California, however, New York state now allows these and other standard business deductions on state returns.
OCM Issues Public Service Announcement
June 20, 2022 – The New York State Office of Cannabis Management (OCM) recently released a public service advertisement calling attention to the state’s goals of creating a diverse and inclusive industry and repairing harm done during cannabis prohibition.
The advertisement released today is the first cannabis related advertisement in the nation focusing on the disproportionate enforcement of cannabis prohibition to appear on broadcast television. It highlights the wide disparity in arrest rates for cannabis offenses for Black, Brown, and White New Yorkers during the 30 years prior to cannabis legalization. It states that Black people in New York were 15 times more likely to get arrested for cannabis than White people over the last 30 years; Latinos were 8 times more likely. Despite these disparities, data has shown that cannabis use among different races is essentially the same. The data points are based on New York State arrest data from data from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
View the PSA here.
Misdemeanor and felony marijuana arrest data by race/ethnicity and county from 1990 to 2020, and notes about the data, are available on the OCM website.
New York Regulators Approve Marketing Rules for Legal Cannabis
June 7, 2022 – New York regulators voted to approve draft regulations for the packaging and advertising of licensed cannabis products in advance of the launch of recreational marijuana sales later this year.
Under the draft regulations from the New York Cannabis Control Board, companies will be permitted to advertise their products on television, radio, social media and other platforms. But the proposed rules include strict provisions designed to protect children from being influenced by cannabis marketing.
“Protecting public health, reducing harm and promoting sustainable industry practices are key components of legalizing cannabis for adult use and I look forward to considering these regulations as we develop the industry,” Cannabis Control Board Chair Tremaine Wright said in a statement quoted by the New York Post. “We are committed to building a New York cannabis industry that sets high standards for protecting children and keeping products safe and sustainable.”
Labels for cannabis products must include the serving size, potency, ingredients, and directions for usage and storage. Packaging and advertising that contain cartoon characters, bubble lettering, neon colors, references to candy, or other elements likely to appeal to person younger than 21 are not allowed.
The regulations also forbid the use of endorsements from celebrities who appear to be younger than 21 and ban the use of common terms in the cannabis culture lexicon including “weed,” “pot,” “stoner,” and “chronic.” Misleading claims of health benefits and indications that the product is “safe” or “organic” are also prohibited, as are actual images of marijuana or people vaping or smoking.
More details about cannabis marketing can be found here.
Green Kulture and Two Chicks and Flowers in partnership with NY Small Farma host “Erasing the Stigma” at Rockland Community College Cultural Arts Center
May 15, 2022 – Erasing the Stigma, is an informational cannabis event on May 20, 2022, 5pm to 8pm at RCC Cultural Arts Center Theater. This FREE event in partnership with NY Small Farma LTD will be produced by NY based cannabis cultivation company Green Kulture; and NY based cannabis lifestyle brand Two Chicks and Flowers. Erasing the Stigma aims to bring awareness to the plight of BIPOC who have been affected by the ‘War on Drugs’ who are now eligible to apply and operate legally in the cannabis industry in New York State.
This informational event was carefully constructed with Rockland county local government officials, cannabis advocates, attorneys, business owners and community leaders aimed to bring awareness and provide information to aspiring New York BIPOC and minority entrepreneurs for the highly anticipated licensing process forthcoming. This initiative is particularly laudable as the cannabis industry continues to grow not only nationally but in New York State, with the entrant of more brands and entrepreneurs POC into the space to meet the growing needs of cannabis consumers.
Green Kulture and NY Small Farma LTD will join forces with Two Chicks and Flowers who recently hosted their cannabis informational event titled “A Piece of The Pot” on December 7, 2021 in Brooklyn’s BedStuy Restoration Plaza which includes a similar layout for Erasing the Stigma.
Registration for ‘Erasing the Stigma’ will be a first come, first RSVP approach as this is a FREE public community event limited to the 500 seats capacity theater via a dedicated EventBrite link. In accordance with New York State guidelines, attendees will be required to provide proof of vaccination prior to entering the venue.
Approval of First 52 Adult-Use Cannabis Conditional Cultivation Licenses to Farms in New York
April 15, 2022 – The Cannabis Control Board approved 52 Adult-use Cannabis Conditional Cultivator Licenses across the state. These are the first adult-use cannabis licenses granted in New York State and they advance the Seeding Opportunity Initiative.
The approved licenses are from a pool of more than 150 that have been submitted to the Office of Cannabis Management (OCM) following the March 15 opening of the online application portal. The OCM will continue to review applications on a rolling basis and will work to get them to the Board for approval as quickly as possible. A list of the licenses approved today is available here.
New Yorkers With Marijuana Convictions Will Get First Retail Licenses
March 9, 2022 – New York State plans to introduce retail sales of marijuana by year-end 2022. Abundant stores of product will be available to licensees grown by New York farmers. New York may also lease storefronts to facilitate the opening of dispensaries. The first licensees must be either a person convicted of a marijuana-related offense or an immediate family member of one.
The policy, to be announced by Gov. Kathy Hochul on Thursday, is part of a concerted push to assure that early business owners in the state’s projected billion-dollar marijuana industry will be members of the communities adversely affected by the state’s criminal justice system. To read the full fact sheet, click here.
CONDITIONAL USE CANNABIS CULTIVATOR LICENSES FOR NY HEMP FARMERS
February 22, 2022 – Governor Kathy Hochul signed legislation creating a new Conditional Adult-use Cannabis Cultivator license, establishing a pathway for existing New York hemp farmers to apply for a conditional license to grow cannabis in the 2022 growing season for the forthcoming adult-use cannabis market. Under the law, conditionally licensed cannabis farmers must meet certain requirements, including safe, sustainable and environmentally friendly cultivation practices, participation in a social equity mentorship program, and engagement in a labor peace agreement with a bona fide labor organization.
With a conditional adult-use cannabis cultivation license, farmers can grow outdoors or in a greenhouse for up to two years from the issuance of the license. It also allows them to manufacture and distribute cannabis flower products without holding an adult-use processor or distributor license, until June 1, 2023. Cultivators are limited to one acre (43,560 square feet) of flowering canopy outdoors or 25,000 square feet in a greenhouse and can use up to 20 artificial lights. They can also split between outdoor and greenhouse grows with a maximum total canopy of 30,000 square feet as long as greenhouse flowering canopy remains under 20,000 square feet.
The OCM will be developing a license application process and opening the program as soon as possible. To qualify for an Adult-use Cannabis Conditional Cultivator License an applicant must have been an authorized industrial hemp research partner for the Department of Agriculture and Markets, cultivating hemp for its non-intoxicating cannabinoid content for at least two of the past four years and in good standing as of December 31, 2021, when the research program ended.
Holders of the license must also participate in a social equity mentorship program where they provide training in cannabis cultivation and processing for social and economic equity partners, preparing them for potential roles in the industry. Growers will also have to meet sustainability requirements to ensure the cannabis is grown in an environmentally conscientious way.
January 16, 2022: Cannabis Career Institute Online (CCI Online) announced today that they are co-hosting a one-day workshop, Cannabis Business Opportunities in New York, with Rockland Community College. The workshop will showcase the full scope (from seed to sale) of business and career opportunities in the New York Cannabis Industry. The workshop will be held virtually on February 10th, 2022. The cost of admission is $219, and you can register here.
Opening remarks for the event will be delivered by Michael A. Baston, President Rockland Community College. Panels will be made up of entrepreneurs, social equity business owners, economic developers as well as municipality representatives, including Grant Valentine, Deputy Mayor for the Village of Chestnut Ridge and Consultant for New York State Cannabis Association of Minorities & Women Professionals.
Panel topics to be discussed include, Seizing Cannabis Market Expansion Opportunities: Social Equity, Diversity & Inclusion, Job Creation as well as Employment & Legal, Banking/Finance, Entrepreneurial Perspectives of Owning Your Own Cannabis Business. By interacting with the extensive list of panelists, participants will gain crucial information needed to successfully enter the emerging market of recreational cannabis and the expanding medical cannabis market.
Rockland Opt-In, Opt-Outs
Towns
| Town | Opt-In | Opt-Out | |
| Clarkstown | |||
| Haverstraw | |||
| Orangetown | |||
| Ramapo | |||
| Stony Point |
Villages
| Villages | Opt-In | Opt-Out | |
| Airmont | Dispensaries | Lounges | |
| Chestnut Ridge | Dispensaries | Lounges | |
| Village of Haverstraw | |||
| Hillburn | |||
| Nyack | Dispensaries | Lounges | |
| Piermont | Dispensaries | Lounges | |
| Pomona | |||
| Sloatsburg | |||
| Spring Valley | |||
| Suffern | |||
| Wesley Hills | |||
| West Haverstraw |
Marijuana Opt-Out Tracker – Brought To Us By The Rockefeller Institute
December 7, 2021 – For an easy to use and up-to-date presentation of New York’s villages’ and towns’ decisions on dispensaries and consumption lounges, check out the Marijuana Opt-Out Tracker by the Rockefeller Institute.
JP Morgan Chase Restricts Trading on Cannabis Stocks
November 3, 2021 – According to Reuters and based on a letter it reviewed, JP Morgan Chase plans on limiting its clients access to US-based securities, effective November 8, 2021. Clients will still be able to liquidate their positions after that date.
Other banks, including Credit Suisse have similarly limited its clients’ abilities to execute transactions or have it hold shares for clients in cannabis-related companies with U.S. operations.
The Chase restrictions apply to companies with U.S. operations that are not listed on the Nasdaq, the New York Stock Exchange or the Toronto Stock Exchange and have a “direct nexus to marijuana-related activities.”
Cowen and Co, another U.S. bank active in the cannabis trading space, in September increased its cash margin requirements for all marijuana related trades on its platform.
Some investors have blamed recent selloffs in U.S. cannabis stocks on banks backing away from the sector and the new restrictions at JPMorgan and Cowen could add to the pressure.
“JPMorgan’s move to block its customers from buying securities in fully legal, regulated cannabis companies is beyond disappointing,” U.S. Cannabis Council CEO Steven Hawkins said in a public statement following the news. “Publicly-traded cannabis companies operate entirely within the law, and the industry is poised for tremendous growth. JPMorgan’s new policy is regressive and at odds with the majority of Americans, who want legal, regulated cannabis. What’s more, it’s self-defeating. The end of federal cannabis prohibition is within site, and the industry is already growing rapidly. I imagine more than a few JPMorgan customers will take issue with being blocked from one of the hottest industries on the market today. JPMorgan is on the wrong side of history on this and will come to regret its decision.”
Nyack Village Board Defers Decision on Cannabis Opt-Out Until November 18, 2021
October 29, 2021 – During a lengthy Zoom meeting last night, the Nyack Village Board took public input on the draft of its local law opting out of both retail cannabis dispensaries and lounges. Citing uncertainty in state regulations and a lack of provisions for dispensaries and lounges in its local zoning code, the Board initially was poised to vote on the Local Law opting out. After several speakers on the Zoom conference spoke in opposition to the plan, the Village Board decided to keep the public hearing open, do additional research, and reconvene on November 18, 2021.
Speakers spoke of lost opportunities for additional tax revenue and the filling of vacant retail space, and misconceptions regarding the availability of dispensary licenses in the future. Residents also pointed out that opting out would only bolster the existing illegal market for cannabis. Others talked about the quality control for the products that licensed dispensaries would provide versus whatever was currently being sold on the streets.
Gifting of Marijuana Illegal in New York If Part of Another Transaction
October 26, 2021 – The gifting of limited amounts of marijuana between adults is not illegal in New York, unless the gifting is part of another transaction. During its October 21st meeting of the Office of Cannabis Management, Tremaine Wright, Chair of the Cannabis Control Board opined on the practice of gifting. Wright said:
“As a reminder to all, we do not yet have state regulated adult use cannabis products on the market. We have not authorized recreational sales. We are hearing many examples of sales of marijuana products by individual vendors and retail locations. However, they are not licensed, nor are they selling regulated products. There are current 38 medical dispensing facilities across the state. We do not have any adult use nor recreational dispensaries. Any individuals selling cannabis or marijuana products in these unlicensed dispensaries, pop up shops or markets is not licensed, nor are they selling safe, tested products. I also wanted to share that any unlicensed sale or distribution of cannabis remains illegal. While gifting or transferring cannabis under the possession limit between adults who are 21 years or older without any money paid or services provided is legal.
Gifting does not include instances in which cannabis is given away at the same time as another transaction nor when it is offered or advertised in conjunction with an offer for the sale of goods or services (emphasis added). There are no legal producers of cannabis other than those whose production is intended for medicinal use. The cannabis being exchanged in the transactions just described those remain illicit. There is no gray market in New York State. This conduct is not legal and must stop. Individuals who do not cease run the risk of severe financial penalties.”
The statements were in response to numerous stories of vendors coupling “gifted” marijuana with sales of over-priced items, under the guise that the marijuana was not actually sold. Wright’s statement likely does not have the force of law. For a full transcript of the meeting, click here.
Town of Ramapo Considers Opting Out of Retail Dispensaries and On-Site Consumption Lounges
October 28, 2021 (UPDATE) – Decision deferred to November 10, 2021 Town Board Meeting
October 26, 2021 – The Town of Ramapo is the latest Rockland County municipal government considering opting out of cannabis retail dispensaries and consumption lounges. At a public hearing on October 13, 2021, the Town Board adjourned without voting and deferred the decision to October 27th’s meeting. The opt-out decision will only affect the unincorporated areas of the Town, not the villages therein. On October 3, 2021, the Village of Suffern in the Town of Ramapo also opted out of retail dispensaries and consumption lounges.
New Workplace Guidance Issued By New York State Department of Labor
October 21, 2021 – The MRTA amended Section 201-D of the New York Labor Law to clarify that cannabis used in accordance with New York State law is a legal consumable product. As such, employers are prohibited from discriminating against employees based on the employee’s use of cannabis outside of the workplace, outside of work hours, and without use of the employer’s equipment or property.
PERMITTED EMPLOYER ACTIONS
The MRTA amended New York Labor Law Section 201-D by adding a new subsection 4-a, which provides that
employers MAY take employment action or prohibit employee conduct where:
• An employer is/was required to take such action by state or federal statute, regulation, or ordinance, or
other state or federal governmental mandate
• The employer would be in violation of federal law
• The employer would lose a federal contract or federal funding
• The employee, while working, manifests specific articulable symptoms of cannabis impairment that decrease or lessen the employee’s performance of the employee’s tasks or duties
• The employee, while working, manifests specific articulable symptoms of cannabis impairment that interfere with the employer’s obligation to provide a safe and healthy workplace as required by state and federal workplace safety laws
Detailed workplace policies are outlined in the DOL Guidance, including drug testing, retaliation for use, termination, reinstatement, off-hours or off-site use, and work-from home use. For a more in depth look, review the guidance here.
The MRTA and New York Labor Law Section 201-D do not apply to individuals who are not employees (e.g., students who are not employees, independent contractors, individuals working out of familial obligation, volunteers) or provide any consumer protections. Employees under the age of 21 are also not covered, as cannabis use by individuals under the age of 21 is prohibited by New York Law and not subject to the present protections. The law also does not apply to employees of the federal government.
H/T: rcbizjournal.com
